研究室紹介
Our Laboratories
研究室紹介
Our Laboratories
総合消化器研究室 膵臓グループ
原著論文
Matsukane R, Minami H, Fujimori N, Ueda K, Komori Y, Takamatsu Y, Ueda T, Kimura M, Matsuzaki C, Tanaka T, Morito A, Kuwahara S, Hashimoto M, Hirai S, Yokoyama T, Ishida S, Hirota T, Ogawa Y, Uchida M.
Prospective study of Anamorelin in pancreatic cancer cachexia: clinical and translational insights into response heterogeneity
Clin Nutr. 2026 Jan 20:58:106581. doi: 10.1016/j.clnu.2026.106581. Online ahead of print.
Ohno A, Fujimori N, Matsumoto K, Haji S, Sugahara O, Takeno A, Yamamoto T, Suenaga A, Kakehashi S, Ueda T, Murakami M, Teramatsu K, Ueda K, Oono T, Oda Y, Nakayama KI, Ogawa Y.
Role of the transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma
Oncogene. 2025 Dec 10. doi: 10.1038/s41388-025-03633-4. Online ahead of print.
Ohba A, Ozaka M, Mizusawa J, Okusaka T, Kobayashi S, Yamashita T, Ikeda M, Yasuda I, Sugimori K, Sasahira N, Ikezawa K, Miki I, Okano N, Mizuno N, Furukawa M, Shirakawa H, Sano Y, Katayama H, Furuse J, Ueno M; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial
J Clin Oncol. 2025 Nov;43(31):3345-3354.
Murakami M, Fujimori N, Suenaga A, Ueda T, Kakehashi S, Furuta A, Ohno A, Matsumoto K, Takamatsu Y, Ueda K, Ogawa Y.
Efficacy and Safety of Duodenal Stenting for Malignant Gastric Outlet Obstruction: Insights From a 15-year Single-Center Experience
DEN Open. 2025 Aug 25;6(1):e70192.
Ogura T, Tanisaka Y, Sekine M, Kobayashi K, Maruyama H, Hirai S, Shiomi H, Shigekawa M, Kuwatani M, Ikezawa K, Itonaga M, Takenaka M, Hijioka S, Ikeura T, Doi S, Fujimori N, Koizumi K, Nakai Y, Inoue T, Mukai S, Matsumoto K, Minami R, Mandai K, Matsuda A, Iwashita T, Kawashima H, Itoi T.
Japanese Multi-Institution Study of Success Rates of Wire-Guided Biliary Cannulation During Endoscopic Retrograde Cholangiopancreatography in Relation to Guidewire tip Length (With Video)
DEN Open. 2025 Jun 16;6(1):e70144.
Koga T, Ishida Y, Hashigo S, Shimokawa Y, Harima H, Okamoto K, Ohno A, Miyagahara T, Fujita T, Fukuchi S, Takahashi K, Taguchi H, Araki N, Ohtsuka Y, Uekitani T, Tsuneyoshi K, Akiyama T, Ishigaki N, Maruo T, Saito H, Ihara R, Yamasuji A, Oe S, Yoshinari M, Sagami R, Fujimori N, Fukuda Y, Ozawa E, Jikuya K, Shinohara H, Sen-Yo M, Ueki T, Tsuchiya N, Kitaguchi T, Matsumoto K, Fukuyama M, Hirai F.
Feasibility and safety of EUS-guided biliary drainage in inexperienced centers: a multicenter study in southwest Japan
Gastrointest Endosc. 2025 Apr;101(4):843-852.e2.
Takeshita K, Hijioka S, Ikezawa K, Ogura T, Kuwatani M, Fujimori N, Doi S, Endo M, Matsubara S, Yamada R, Mashima H, Kataoka M, Takada R, Okuda A, Ohno A, Katsukura N, Suzuki H, Tanaka T, Sekine M, Kitamura H, Okusaka.
Uncovered Self Expandable Metallic Stent with an Ultra Thin Delivery Sheath in Unresectable Malignant Hilar Biliary Obstruction: A Multicenter Prospective Observational Study
Dig Dis Sci. 2025 Apr;70(4):1560-1572.
Shibuki T, Ikeda M, Yokoyama M, Sano Y, Furuse J, Kobayashi S, Ohba A, Todaka A, Horie T, Shoji K, Kanai M, Nishina T, Kumamoto Y, Fujimori N, Katanuma A, Takayama Y, Tsumura H, Miwa H, Ozaka M, Ueno M.
Depth of response in patients with locally advanced pancreatic cancer treated with first-line chemotherapy: a supplementary analysis of JCOG1407
Pancreatology. 2025 Feb 10:S1424-3903(25)00033-X.
Fujimori N, Fujita N, Murakami M, Ohno A, Matsumoto K, Teramatsu K, Ueda K, Wada N, Takao S, Okamoto D, Ishigami K, Ito T, Ogawa Y.
Usefulness of semi-automated 3D volumetric assessment of liver tumor burden for patients with unresectable pancreatic neuroendocrine tumor: A pilot study
Pancreas. 2025 Feb 1;54(2):e122-e129.
Minoda Y, Suzuki Y, Ogino H, Nagatomo S, Xiaopeng Bai, Esaki M, Wada M, Tanaka Y, Hata Y, Fujimori N, Umekita S, Tsurumaru D, Ota M, Oki E, Ihara E, Ogawa Y.
Traction-assisted endoscopic ultrasound-guided fine-needle biopsy using the clip-with-thread method for small gastric subepithelial lesions: Randomized controlled trial (with video)
Digestive Endoscopy. 2025 May;37(5):512-520.
Ikenaga N, Nakata K, Abe T, Watanabe Y, Ideno N, Murakami M, Ueda K, Fujimori N, Fujita N, Ishigami K, Ogawa Y, Nakamura M.
Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma
Surgery. 2025 Feb 178:108958.
Sano T, Kikuta K, Takikawa T, Matsumoto R, Okazaki K, Takeyama Y, Masamune A; Japan Pancreatitis Study Group for AIP (JPSG-AIP).
Serum IgG4-negative and IgG4-positive type 1 autoimmune pancreatitis present with different clinicopathological features: An analysis of a nationwide survey in Japan
Pancreatology. 2025 Feb;25(1):82-88.
Ohno A, Fujimori N, Kaku T, Matsumoto K, Murakami M, Teramatsu K, Ueda K, Hijioka M, Aso A, Ogawa Y.
Puncture angle on an endoscopic ultrasound image is independently associated with unsuccessful guidewire maniqulation of endscopic ultrasound-guided hepaticogastrostomy: a retrospective study in Japan.
Clin Endosc. 2024 Sep;57(5):656-665.
Ohno A, Fujimori N, Kaku T, Shimokawa Y, Miyagahara T, Suehiro Y, Gerodias A, Kakehashi S, Matsumoto K, Murakami M, Ueda K, Ogawa Y.
Feasibility of Endoscopic Ultrasound-Guided Hepaticogastrostomy for Malignant Hilar Biliary Obstruction
Dig Dis Sci. 2025 Jan;70(1):419-428.
Koga T, Ishida Y, Hashigo S, Shimokawa Y, Harima H, Okamoto K, Ohno A, Miyagahara T, Fujita T, Fukuchi S, Takahashi K, Taguchi H, Araki N, Ohtsuka Y, Uekitani T, Tsuneyoshi K, Akiyama T, Ishigaki N, Maruo T, Saito H, Ihara R, Yamasuji A, Oe S, Yoshinari M, Sagami R, Fujimori N, Fukuda Y, Ozawa E, Jikuya K, Shinohara H, Sen-Yo M, Ueki T, Tsuchiya N, Kitaguchi T, Matsumoto K, Fukuyama M, Hirai F.
Feasibility and safety of endoscopic ultrasound-guided biliary drainage in inexperienced centers: a multicenter study in Southwest Japan
Gastrointest Endosc. 2025 Apr;101(4):843-852.e2.
Saito T, Takenaka M, Kuwatani M, Doi S, Ohyama H, Fujisawa T, Masuda A, Iwashita T, Shiomi H, Hayashi N, Iwata K, Maruta A, Mukai T, Matsubara S, Hamada T, Inoue T, Matsumoto K, Hirose S, Fujimori N, Kashiwabara K, Kamada H, Hashimoto S, Shiratori T, Yamada R, Kogure H, Nakahara K, Ogura T, Kitano M, Yasuda I, Isayama H, Nakai Y; WONDERFUL study group in Japan and collaborators.
WONDER-02: plastic stent vs. lumen-apposing metal stent for endoscopic ultrasound-guided drainage of pancreatic pseudocysts-study protocol for a multicentre randomised non-inferiority trial.
Trials. 2024 Aug 24;25(1):559.
Ogura T, Ishiwatari H, Hijioka S, Takeshita K, Sato J, Takenaka M, Fukunaga T, Omoto S, Fujimori N, Ohno A, Hatamaru K, Tamura T, Imai H, Yamada M, Hakoda A, Nishikawa H, Kitano M.
Multicenter study comparing EUS-guided hepaticogastrostomy and ERCP for malignant biliary obstruction in patients with accessible papillae
J Hepatobiliary Pancreat Sci. 2024 Sep;31(9):680-687.
Ishiwatari H, Kawabata T, Kawashima H, Nakai Y, Miura S, Kato H, Shiomi H, Fujimori N, Ogura T, Inatomi O, Kubota K, Fujisawa T, Takenaka M, Mori H, Noguchi K, Fujii Y, Sugiura T, Ideno N, Nakafusa T, Masamune A, Isayama H, Sasahira N.
Endoscopic nasobiliary drainage versus endoscopic biliary stenting for preoperative biliary drainage in patients with malignant hilar biliary obstruction: Propensity score-matched multicenter comparative study
Dig Endosc. 2024 Jun;36(6): 726-734.
Matsumoto K, Fujimori N, Ichihara K, Takeno A, Murakami M, Ohno A, Kakehashi S, Teramatsu K, Ueda K, Nakata K, Sugahara O, Yamamoto T, Matsumoto A, Nakayama KI, Oda Y, Nakamura M, Ogawa Y.
Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction.
J Gastroenterol. 2024 Jul;59(7):629-640.
Murakami M, Fujimori N, Takamatsu Y, Ito T, Matsumoto K, Kakehashi S, Ohno A, Teramatsu K, Ueda K, Ishigami K and Ogawa Y.
Efficacy and safety of streptozocin-based chemotherapy for gastroenteropancreatic neuroendocrine tumors in Japanese clinical practice
Jpn J Clin Oncol. 2024 Jun 1;54(6):647-657.
Takikawa T, Kikuta K, Sano T, Ikeura T, Fujimori N, Umemura T, Naitoh I, Nakase H, Isayama H, Kanno A, Kamata K, Kodama Y, Inoue D, Ido A, Ueki T, Seno H, Yasuda H, Iwasaki E, Nishino T, Kubota K, Arizumi T, Tanaka A, Uchida K, Matsumoto R, Hamada S, Nakamura S, Okazaki K, Takeyama Y, Masamune A; Japan Pancreatitis Study Group for AIP.
Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan
Pancreatology. 2024 May;24(3):335-342.
Mizuno N, Ioka T, Ogawa G, Nakamura S, Hiraoka N, Ito Y, Katayama S< Takada R, Kobayashi S, Ikeda M, Muwa H, Okano N, Kuramochi H, Sekimoto M, Okusaka T, Ozaka M, Todaka A, Gotoh K, Tobimatsu K, Yamaguchi H, Nakagohri T, Kajiura S, Sudo K, Okamura K, Shimizu S, Shirakawa H, Kato N, Sano K, Iwai T, Fujimori N, Ueno M, Ishii H, Furuse J and Hepatobiliary and Pancreatic Oncology Group (HBPOG) of Japan Clinical Oncology Group (JCOG)
Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemic inflammatory response in JCOG1106
Jpn J Clin Oncol. 2023 Jul 31;53(8):704-713.
Murakami M, Fujimori N, Nakata K, Nakamura M, Hashimoto S, Kurahara H, Nishihara K, Abe T, Hashigo S, Kugiyama N, Ozawa E, Okamoto K, Ishida Y, Okano K, Takaki R, Shimamatsu Y, Ito T, Miki M, Oza N, Yamaguchi D, Yamamoto H, Takedomi H, Kawabe K, Akashi T, Miyahara K, Ohuchida J, Ogura Y, Nakashima Y, Ueki T, Ishigami K, Umakoshi H, Ueda K, Oono T, Ogawa Y.
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2
J Gastroenterol. 2023 Jun;58(6):586-597.
Ishiwatari H, Kawabata T, Kawashima H, Nakai Y, Miura S, Kato H, Shiomi H, Fujimori N, Ogura T, Inatomi O, Kubota K, Fujisawa T, Takenaka M, Mori H, Noguchi K, Fujii Y, Sugiura T, Ideno N, Nakafusa T, Masamune A, Isayama H, Sasahira N.
Clinical Outcomes of Inside Stents and Conventional Plastic Stents as Bridge-to-Surgery Options for Malignant Hilar Biliary Obstruction.
Dig Dis Sci. 2023 Apr;68(4):1139-1147.
Ozaka M, Nakachi K, Kobayashi S, Ohba A, Imaoka H, Terashima T, Ishii H, Mizusawa J, Katayama H, Kataoka T, Okusaka T, Ikeda M, Sasahira N, Miwa H, Mizukoshi E, Okano N, Mizuno N, Yamamoto T, Komatsu Y, Todaka A, Kamata K, Furukawa M, Fujimori N, Katanuma A, Takayama Y, Tsumura H, Fukuda H, Ueno M, Furuse J; Hepatobiliary and Pancreatic Oncology Group of Japan Clinical Oncology Group (JCOG).
A randomized phase Ⅱ study of modified FOLFIRINOX versus gemcitabine plusnab-paclitaxel for locally advanced pancreatic cancer (JCOG1407).
Eur J Cancer. 2023 Mar;181:135-144.
Ikenaga N, Nakata K, Abe T, Ideno N, Fujimori N, Oono T, Fujita N, Ishigami K, Nakamura M.
Risks and benefits of pancreaticoduodenectomy in patients aged 80 years and over
Langenbecks Arch Surg. 2023 Feb 27;408(1):108.
Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, Todaka A, Yanagimoto H, Morinaga S, Kobayashi S, Shimada K, Takahashi Y, Nakagohri T, Gotoh K, Kamata K, Shimizu Y, Ueno M, Ishii H, Okusaka T, Furuse J, Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial
Lancet. 2023 Jan 21; 401(10372):195-203.
Ohno A, Fujimori N, Kaku T, Takamatsu Y, Matsumoto K, Murakami M, Teramatsu K, Takeno A, Hijioka M, Kawabe K, Harada N, Nakamuta M, Aso A, Oono T, Ogawa Y.
Feasibility and Efficacy of Endoscopic Ultrasound-Guided Hepaticogastrostomy Without Dilation: A Propensity Score Matching Analysis.
Dig Dis Sci. 2022 Dec;67(12):5676-5684.
Miyagahara T, Fujimori N, Ueda K, Takamatsu Y, Matsumoto K, Teramastu K, Takaoka T, Suehiro Y, Shimokawa Y, Omori K, Niina Y, Tachibana Y, Akashi T, Oono T, Ogawa Y.
Incidence and appropriate management of drug-induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study.
Asia Pac J Clin Oncol. 2023 Aug;19(4):533-541.
Ohno A, Fujimori N, Kaku T, Hijioka M, Kawabe K, Harada N, Nakamuta M, Oono T, Ogawa Y.
The feasibility of percutaneous transhepatic gallbladder aspiration for acute cholecystitis after self-expandable metallic stent placement for malignant biliary obstruction: a 10-year retrospective analysis in a single center.
Clin Endosc. 2022 Nov;55(6):784-792.
Shibata K. Motozono C, Nagae M, Shimizu T, Ishikawa E, Motooka D, Okuzaki D, Izumi Y, Takahashi M, Fujimori N, Wing JB, Hayano T, Asai Y, Bamba T, Ogawa Y, Furutani-Seiki Makoto, Shirai M, Yamasaki S.
Symbiotic bacteria-dependent expansion of MR1-reactive T cells causes autoimmunity in the absence of Bcl11b
Nat Commun. 2022 Nov 14;13(1):6948.
Teramatsu K, Oono T, Oyama K, Fujimori N, Murakami M, Yasumori S, Ohno A, Matsumoto K, Takeno A, Nakata K, Nakamura M, Ogawa Y.
Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer
BMC Cancer. 2022 Nov 4;22(1):1134.
Miki M, Fujimori N, Ueda K, Lee L, Murakami M, Takamatsu Y, Shimokawa Y, Niina Y, Oono T, Hisano T, Furukawa M, Ogawa Y.
Treatment effect and safety of nanoliposomal irinotecan with fluorouracil and folinic acid after gemcitabine-based therapy in patients with advanced pancreatic cancer: A multicenter, prospective observational study.
J Clin Med. 2022 Aug 30;11(17):5084.
Takamatsu Y, Fujimori N, Miyagahara T, Suehiro Y, Kaku T, Kawabe K, Ohno A, Matsumoto K, Murakami M, Teramatsu K, Takeno A, Oono T, Ogawa Y.
The Glasgow Prognostic Score and stricture site can predict prognosis after endoscopic duodenal stent placement for malignant gastric outlet obstruction.
Sci Rep. 2022 Jun 13;12(1):9746.
Matsumoto K, Fujimori N, Hata Y, Minoda Y, Murakami M, Teramatsu K, Takamatsu Y, Takeno A, Oono T, Ihara E, Nakata K, Nakamura M, Yamamoto T, Koga Y, Oda Y, Ito T, Ogawa Y.
Ampullary Neuroendocrine Neoplasm: Clinicopathological Characteristics and Novel Endoscopic Entity.
Dig Dis. 2023;41(2):316-324.
Murakami M, Fujimori N, Matsumoto K, Ohno A, Teramatsu K, Takamatsu Y, Takeno A, Ueda K, Oono T, Ito T, Ogawa Y.
A clinical analysis on functioning pancreatic neuroendocrine tumors (focusing on VIPomas): a singlecenter experience.
Endocr J. 2022 Oct 28;69(10):1201-1209.
Murakami M, Fujimori N, Ohno A, Matsumoto K, Teramatsu K, Takamatsu Y, Takeno A, OonoT, Abe T, Ideno N, Ikenaga N, Nakata K, Nakamura M, Ishigami K, Ogawa Y.
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: A single-center retrospective study.
Discover Oncology, vol13(1) 2022 Jan 3;13(1):2.
Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, Nakamura K, Nakamoto Y, Hijioka S, Morita K, Ishikawa Y, Ohike N, Kasajima A, Kushima R, Kojima M, Sasano H, Hirano S, Mizuno N, Aoki T, Aoki T, Ohtsuka T, Okumura T, Kimura Y, Kudo A, Konishi T, Matsumoto I, Kobayashi N, Fujimori N, Honma Y, Morizane C, Uchino S, Horiuchi K, Yamasaki M, Matsubayashi J, Sato Y, Sekiguchi M, Abe S, Okusaka T, Kida M, Kimura W, Tanaka M, Majima Y, Jensen RT, Hirata K, Imamura M, Uemoto S.
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
J Gastroenterol. 2021 Nov;56(11):1033-1044.
Okuno H, Ogino H, Ihara E, Nishioka K, Tanaka Y, Chinen T, Kohjima M, Oono T, Tanaka M, Goya T, Fujimori N, Iboshi Y, Gotoda T, Ogawa Y.
Discriminant equation using mucosally expressed cytokines and transcription factor for making definite diagnosis of inflammatory bowel disease unclassified
BMC Gastroenterol. 2021 Feb 16;21(1):73.
Fujimori N, Osoegawa T, Aso A, Itaba S, Minoda Y, Murakami M, Matsumoto K, Teramatsu K, Takamatsu Y, Takaoka T, Oono T, Ihara E, Yoshizumi T, Ohtsuka T, Nakamura M, Ogawa Y.
Efficacy of early endoscopic ultrasound-guided transluminal drainage for postoperative pancreatic fistula.
Can J Gastroenterol Hepatol. 25;2021:6691705. eCollection 2021
Minaga K, Takenaka M, Ogura T, Tamura T, Kuroda T, Kaku T, Uenoyama Y, Noguchi C, Nishikiori H, Imai H, Sagami R, Fujimori N, Higuchi K, Kudo M, Chiba Y, Kitano M.
Endoscopic ultrasound-guided biliary drainage for malignant biliary obstruction with surgically altered anatomy: a multicenter prospective registration study.
Therap Adv Gastroenterol. 13:1-11, 2020
Ito T, Fujimori N, Honma Y, Kudo A, Hijioka S, Katsushima S, Kimura Y, Fukutomi A, Hisamatsu S, Nakajima A, Shimatsu A.
Long-term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open-label extension study.
Asia Pac J Clin Oncol. 2021 Oct;17(5):e153-e161.
Masamune A, Kikuta K, Kume K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K; Japan Pancreas Society
Nationwide epidemiological survey of chronic pancreatitis in Japan: introduction and validation of the new Japanese diagnostic criteria 2019.
J Gastroenterol. 55:1062-1071, 2020
Miyasaka Y, Ohtsuka T, Kimura R, Matsuda R, Mori Y, Nakata K, Kakihara D, Fujimori N, Ohno T, Oda Y, Nakamura M.
Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer Potentially Improves Survival and Facilitates Surgery.
Ann Surg Oncol. 26:1528-1534, 2019
Miki M, Fujimori N, Oono T, Kawabe K, Ohno A, Matsumoto K, Teramatsu K, Tachibana Y, Ogawa Y.
Relapse patterns and predictors of IgG4-related diseases involved with autoimmune pancreatitis: A single-center retrospective study of 115 patients.
J Dig Dis. 20:152-158, 2019
Toriyama K, Hijioka S, Komoto I, Kobayashi N, Okusaka T, Ku Y, Sudo K, Furukawa M, Tachibana Y, Takahashi M, Yasuda H, Nakamori S, Honma Y, Kida M, Fujimori N, Kashiwada T, Masui T, Ishii H, Tsuchiya Y, Isaji S, Mizuno N, Hara K, Sakamine M, Imamura M, Kagimura T, Ito T.
Study Protocol for Prospective Observational Study 1 on the Prognosis of Patients with Unresectable Advanced Gastrointestinal and Pancreatic Neuroendocrine Tumors (PROP-UP 1 Study) in Japan.
J Clin Trials Vol 8(4) 2018
Ohtsuka T, Gotoh Y, Nakashima Y, Okayama Y, Nakamura S, Morita M, Aly MYF, Velasquez VVDM, Mori Y, Sadakari Y, Nakata K, Miyasaka Y, Ishigami K, Fujimori N, Mochidome N, Oda Y, Shimizu S, Nakamura M.
Role of SpyGlass-DStm in the preoperative assessment of pancreatic intraductal papillary mucinous neoplasm involving the main pancreatic duct.
Pancreatology. 18; 566-571, 2018
Yasunaga K, Ito T, Miki M, Ueda K, Fujiyama T, Tachibana Y, Fujimori N, Kawabe K, Ogawa Y.
Using CRISPR/Cas9 to Knock out Amylase in Acinar Cells.
Biomed Res Int. 87:19397, 2018
Lee L, Ito T, Igarashi H, Miki M, Fujimori N, Kawabe K, Jensen RT, Ogawa Y.
Dose and schedule modification are required for long-term continuation of sunitinib in Japanese patients with advanced pancreatic neuroendocrine tumors.
Cancer Chemother Pharmacol. 81:163-169, 2018
Ueda K, Kawabe K, Lee L, Tachibana Y, Fujimori N, Igarashi H, Oda Y, Jensen RT, Takayanagi R, Ito T.
Diagnostic Performance of 48-Hour Fasting Test and Insulin Surrogates in Patients With Suspected Insulinoma.
Pancreas. 46:476-481, 2017
Niina Y, Ito T, Ueda K, Lee L, Igarashi H, Hijioka M, Takaoka T, Fujiyama T, Miki M, Tachibana Y, Fujimori N, Ohtsuka T, Nakamura K, Kawabe K, Ogawa Y.
Effectiveness of endoscopic duodenal stenting for the management of patients with unresectable pancreatic cancer.
Gastroenterol Hepatol Endosc, 2:1-5, 2017
Ito T, Ishiguro H, Ohara H, Kamisawa T, Sakagami J, Sata N, Takeyama Y, Hirota M, Miyakawa H, Igarashi H, Lee L, Fujiyama T, Hijioka M, Ueda K, Tachibana Y, Sogame Y, Yasuda H, Kato R, Kataoka K, Shiratori K, Sugiyama M, Okazaki K, Kawa S, Tando Y, Kinoshita Y, Watanabe M, Shimosegawa T.
Evidence-based Clinical Practice Guidelines for Chronic Pancreatitis 2015.
J Gastroenterol 51: 85-92, 2016
Nakamura K, Osada M, Iwasa T, Takahashi S, Takizawa N, Akahoshi K, Ochiai T, Nakamura N, Akiho H, Itaba S, Harada N, Iju M, Tanaka M, Kubo H, Somada S, Ihara E, Oda Y, Ito T, Takayanagi R.
Short- and long-term outcomes of endoscopic resection of rectal neuroendocrinetumors: analyses according to the WHO 2010 classification.
Scand J Gastroenterol 51: 448-455, 2016
Notohara K, Nishimori I, Mizuno N, Okazaki K, Ito T, Kawa S, Egawa S, Kihara Y, Kanno A, Masamune A, Shimosegaw T.
Clinicopathological Features of Type 2 Autoimmune Pancreatitis in Japan: Results of a Multicenter Survey.
Pancreas. 44: 1072-1077, 2015
Kawa S, Okazaki K, Notohara K, Ueki T, Matsui T, Kanno A, Watanabe T, Uchida K, Taguchi M, Igarashi H, Ito T, Igarashi H, Kawanobe T, Iijima H, Kohgo Y, Ito T, Kunisaki R, Nagahori M, Itoi T, Honjo M, Sakagami J, Yasuda H, Hatakeyama K, Iiai T, Hirooka Y, Sumi H, Watanabe K, Sasaki M, Ando A, Inatomi O, Kinjo F, Iraha A, Fujita N, Masu K, Kagaya T, Miyakawa H, Okamura K, Hibi N, Nakamura Y, Fukuda K, Ikeura T, Ishikawa T, Ueno F, Satoh A, Uemura M, Tsubouchi H, Funakawa K, Iizuka M, Yoden A, Kubota K, Funayama Y, Eguchi T, Ishigro Y, Uehara N, Arakura N, Kamisawa T, Nishimori I, Ohara H, Mizuno N, Hirano K, Masamune A, Kikuta K, Watanabe M, Shimosegawa T.
Autoimmune Pancreatitis Complicated with Inflammatory Bowel Disease and
Comparative Study of Type 1 and Type 2 Autoimmune Pancreatitis.
J Gastroenterol. 50: 805-815, 2015
Watanabe Y, Ohtsuka T, Matsunaga T, Kimura H, Tamura K, Ideno N, Aso T, Miyasaka Y, Ueda J, Takahata S, Igarashi H, Inoguchi T, Ito T, Tanaka M.
Long-Term Outcomes After Total Pancreatectomy: Special Reference to Survivors' Living Conditions and Quality of Life.
World J Surg. 39: 1231-1239, 2015
Ito T, Igarashi H, Nakamura K, Sasano H, Okusaka T, Yakano K, Komoto I, Tanaka M, Imamura M, Jensen RT, Takayanagi R, Shimatsu A.
Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis.
J Gastroenterol.50: 58-64, 2015
Aoki T, Kokudo N, Komoto I, Takaori K, Kimura W, Sano K, Takamoto T, Hashimoto T, Okusaka T, Morizane C, Ito T, Imamura M.
Streptozocin chemotherapy for advanced/metastatic well-differentiated neuroendocrine tumors: an analysis of multi-center survey in Japan.
J Gastroenterol. 50: 769-775, 2015
Ito T, Lee L, Hijioka M, Kawabe K, Kato M, Nakamura K, Ueda K, Ohtsuka T, Igarashi H.
The up-to-date review of epidemiological pancreatic neuroendocrine tumors in Japan.
J Hepatobiliary Pancreat Sci. 22: 574-547, 2015
Igarashi H, Hijioka M, Lee L, Ito T.
Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs.
J Hepatobiliary Pancreat Sci. 22: 618-622, 2015
Lee L, Igarashi H, Fujimori N, Hijioka M, Kawabe K, Oda Y, Jensen RT, Ito T.
Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine tumors:a single-center retrospective study.
Jpn J Clin Oncol. 45: 1131-1138, 2015
Hijioka M, Ito T, Igarashi H, Fujimori N, Lee L, Nakamura T, Jensen RT, Takayanagi R.
Serum Chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumor.
Cancer Sci. 105: 1464-1471, 2014
Niina Y, Ito T, Oono T, Nakamura T, Fujimori N, Igarashi H, Sakai Y, Takayanagi R.
A sustained prostacyclin analog, ONO-1301, attenuates pancreatic fibrosis in experimental chronic pancreatitis induced by dibutyltin dichloride in rats.
Pancreatology. 14:201-10. 2014
Ohtsuka T, Tamura K, Ideno N, Aso T, Nagayoshi Y, Kono H, Ueda J, Takahata S, Aso A, Igarashi H, Ito T, Ushijima Y, Ookubo F, Oda Y, Mizumoto K, Tanaka M.
The role of ERCP in the era of EUS-FNA for preoperative cytological confirmation of resectable pancreatic ductal adenocarcinoma.
Surg Today. 44: 1887-1892, 2014
Kamisawa T, Okazaki T, Kawa S, Shimosegawa T, Tanaka M, Nishimori I, Ito T, Tanaka S, and Working members of Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society.
Amendment of Japanese Consensus Guideline for Management of Autoimmune Pancreatitis,2013. III. Treatment and prognosis of AIP.
J Gastroenterol. 49: 961-970, 2014
Kawa S, Okazaki K, Kamisawa T, Kubo K, Ohara H, Hasebe O, Fujinaga Y, Irisawa A, Notohara K, Ito T, Inui K, Irie H, Nishino T, Nishimori I, Tanaka S, Nishiyama T, MD, Suda K, Shiratori K, Tanaka M, Shimosegawa T.
Amendment of Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013.II. Extra-pancreatic lesions, differential diagnosis.
J Gastroenterol. 49: 765-784, 2014
Okazaki T, Kawa S, Kamisawa T, Ito T, Inui K, Irie H, Nishino T, Notohara K, Nishimori I, Tanaka S, Nishiyama T, Suda K, Shiratori K, Tanaka M, Shimosegawa T, and Working members of Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society.
Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013.I. Concept and diagnosis of autoimmune pancreatitis.
J Gastroenterol. 49: 567-588, 2014
Uchida M, Ito T, Nakamura T, Hijioka M, Igarashi H, Oono T, Kato M, Nakamura K, Suzuki K, Takayanagi R, Jensen RT.
Pancreatic stellate cells and CX3CR1: occurrence in normal pancreas, acute and chronic pancreatitis and effect of their activation by a CX3CR1 agonist.
Pancreas. 43: 708-719, 2014
Ishigami K, Nishie A, Asayama Y, Ushijima Y, Takayama Y, Fujita N, Takahata S, Ohtsuka T, Ito T, Igarashi H, Ikari S, Metz CM, Honda H.
Imaging pitfalls of pancreatic serous cystic neoplasm and its potential mimickers.
World J Radiol. 6: 36-47, 2014
Nagayoshi Y, Aso T, Ohtsuka T, Kono H, Ideno N, Igarashi H, Takahata S, Oda Y, Ito T, Tanaka M.
Peroral pancreatoscopy using the SpyGlass system for the assessment of Intraductal papillary mucinous neoplasm of the pancreas.
J Hepatobiliary Pancreat Sci. 21: 410-417, 2014
Aso A, Ihara E, Osoegawa T, Nakamura K, Itaba S, Igarashi H, Ito T, Aishima S, Oda Y, Tanaka M, Takayanagi R.
Key Endoscopic Ultrasound Features of Pancreatic Ductal Adenocarcinoma Smaller than 20 mm.
Scand J Gastroenterol. 49: 332-338, 2014
Nagayoshi Y, Nakamura M, Matsuoka K, Ohtsuka T, Mori Y, Kono H, Aso T, Ideno N, Takahata S, Ryo A, Takeda H, Ito T, Oda Y, Endo Y, Sawasaki T, Tanaka M.
Profiling of autoantibodies in sera of pancreatic cancer patients.
Ann Surg Oncol. 21: 459-465, 2014
Nakamura T, Ito T, Uchida M, Hijioka M, Igarashi H, Oono T, Kato M, Nakamura K, Suzuki K, Jensen RT, Takayanagi R.
PSCs and GLP-1R: occurrence in normal pancreas, acute/chronic pancreatitis and effect of their activation by a GLP-1R agonist.
Lab Invest. 94: 63-78, 2014
Igarashi H, Ito T, Nishimori I, Yamasaki I, Shuin T.
Pancreatic involvement in Japanese patients with von Hippel-Lindau disease: results of a nationwide survey.
J Gastroenterol. 49: 511-516, 2014
Fujimori N, Igarashi H, Asou A, Kawabe K, Lee L, Oono T, Nakamura T, Niina Y, Hijioka M, Uchida M, Kotoh K, Nakamura K, Ito T, Takayanagi R.
Endoscopic approach through the minor papilla in the management of pancreatic diseases.
World J Gastrointest Endosc. 5: 81-88, 2013
Uchida M, Ito T, Nakamura T, Igarashi H, Oono T, Fujimori N, Kawabe K, Suzuki K, Jensen RT, Takayanagi R.
ERK pathway and sheddases play an essential role in ethanol-induced CX3CL1 release in pancreatic stellate cells.
Lab Invest.93:41-53, 2013
Otsuki M, Takeda K, Matsuno S, Kihara Y, Koizumi M, Hirota M, Ito T, Kataoka K, Kitagawa M, Inui K, Takeyama Y.
Criteria for the diagnosis and severity stratification of acute pancreatitis.
World J Gastroenterol. 19: 5798-5805, 2013
Ohtsuka T, Ideno N, Aso T, Nagayoshi Y, Kono H, Mori Y, Takahata S, Oda Y, Aishima S, Igarashi H, Ito T, Ishigami K, Nakamura M, Mizumoto K, Tanaka M.
Role of endoscopic retrograde pancreatography for early detection of Pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas.
J Hepatobiliary Pancreat Sci. 20: 356-361, 2013
Ito T, Okusaka T, Nishida T, Igarashi H, Mizuno N, Hara K, Morizane C, Kondo S, Hashigaki S, Kimura N, Okano K, Tanuma J, Murakami M, Sawaki A, Yamao K, Imamura M.
Phase II Study of Sunitinib in Japanese Patients with Unresectable or Metastatic, Well-differentiated Pancreatic Neuroendocrine Tumor.
Invest New Drugs. 31: 1265-1274, 2013
Ito T, Igarashi H, Uehara H, Berma MJ, Jense RT.
Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1 With Pancreatic Endocrine Tumor and Zollinger-Ellison Syndrome: Prospective Study of 106 Cases and Review of the Literature.
Medicine (Baltimore). 92: 135-181, 2013
Nakamura T, Ito T, Igarashi H, Uchida M, Hijioka M, Oono T, Fujimori N, Niina Y, Suzuki K, Jensen RT, Takayanagi R.
Cytosolic double-stranded DNA as a damage-associated molecular pattern induces the inflammatory response in rat pancreatic stellate cells: a plausible mechanism for tissue injury-associated pancreatitis.
Int J Inflam.2:504128. 2012
Igarashi H, Ito T, Oono T, Nakamura T, Fujimori N, Niina Y, Hijioka M, Uchida M, Lee R, Iwao R, Nakamura K, Kotoh K, Takayanagi R.
Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases.
J Dig Dis.13:274-9, 2012
Ohtsuka T, Kono H, Tanabe R, Nagayoshi Y, Mori Y, Sadakari Y, Takahata S, Oda Y, Aishima S, Igarashi H, Ito T, Ishigami K, Nakamura M, Mizumoto K, Tanaka M.
Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas.
Am J Surg. 204: 44-48, 2012
Nakamura T, Ito T, Suzuki K, Uchida M, Igarashi H, Jensen RT, Takayanagi R.
Cytosolic double-stranded DNA as damage-associated molecular-patters induced inflammatory responses in rat pancreatic stellate cells ~ plausible mechanism for tissue-injury associated pancreatitis.
Int J Inflam. 2012: 504128, 2012
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui K, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H for the All Japan IgG4 team.
Comprehensive Diagnostic Criteria (CDC criteria) for IgG4-related disease(IgG4-RD), 2011.
Mod Rheumatol. 22: 21-30, 2012
Tsutsumi K, Ohtsuka T, Mori Y, Fujino M, Yasui T, Aishima S, Takahata S, Nakamura M, Ito T, Tanaka M.
Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.
J Gastroenterol. 47: 678-685, 2012
Ito T, Okusaka T, Ikeda M, Igarashi H, Morizane C, Nakachi K, Tajima T, Kasuga A, Fujita Y, Furuse J.
Everolimus for Advanced Pancreatic Neuroendocrine Tumors: A Subgroup Analysis Evaluating Japanese Patients in the RADIANT-3 Trial.
Jpn J Clin Oncol. 42: 903-911, 2012
Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EG, Tomassetti P, Pavel ME, Hoosen S, Haas T, Lincy J, Lebwohl D, Öberg K.
RAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study Group.
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
N Engl J Med. 364: 514-523, 2011
Okusaka T, Furuse J, Funakoshi A, Ioka T, Yamao K, Ohkawa S, Boku N, Komatsu Y, Nakamori S, Iguchi H, Ito T, Nakagawa K, Nakachi K.
Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer.
Cancer Sci. 102: 425-443, 2011
Fujimori N, Oono T, Igarashi H, Ito T, Nakamura T, Uchida M, Coy DH, Jensen RT, Takayanagi R.
Vasoactive intestinal peptide reduces oxidative stress in pancreatic acinar cells through the inhibition of NADPH oxidase.
Peptides. 32:2067-76, 2011
Nakamura T, Ito T, Oono T, Igarashi H, Fujimori N, Uchida M, Niina Y, Yasuda M, Suzuki K, Takayanagi R.
Bacterial DNA promotes proliferation of rat pancreatic stellate cells thorough toll-like receptor 9: potential mechanisms for bacterially induced fibrosis.
Pancreas. 40:823-31, 2011
Ito T, Nakamura T, Fujimori N, Niina Y, Igarashi H, Oono T, Uchida M, Kawabe K, Takayanagi R, Nishimori I, Otsuki M, Shimosegawa T.
Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis.
J Dig Dis. 12:210-6, 2011
Ito T, Sasano H, Tanaka M, Osamura RY, Sasaki I, Kimura W, Takano K, Obara T, Ishibashi M, Nakao K, Doi R, Shimatsu A, Nishida T, Komoto I, Hirata Y, Nakamura K, Igarashi H, Jensen RT, Wiedenmann B, Imamura M.
Epidemiological Study of Gastroenteropancreatic Neuroendocrine Tumors in Japan.
J Gastroenterol. 45: 234-243, 2010
Ito T, Otsuki M, Igarashi H, Kihara Y, Kawabe K, Nakamura T, Fujimori N, Oono T, Takayanagi R, Shimosegawa T.
Epidemiological Study of Pancreatic Diabetes in Japan in 2005: A Nationwide Study.
Pancreas. 39:829-835, 2010
Prospective study of Anamorelin in pancreatic cancer cachexia: clinical and translational insights into response heterogeneity
Clin Nutr. 2026 Jan 20:58:106581. doi: 10.1016/j.clnu.2026.106581. Online ahead of print.
Ohno A, Fujimori N, Matsumoto K, Haji S, Sugahara O, Takeno A, Yamamoto T, Suenaga A, Kakehashi S, Ueda T, Murakami M, Teramatsu K, Ueda K, Oono T, Oda Y, Nakayama KI, Ogawa Y.
Role of the transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma
Oncogene. 2025 Dec 10. doi: 10.1038/s41388-025-03633-4. Online ahead of print.
Ohba A, Ozaka M, Mizusawa J, Okusaka T, Kobayashi S, Yamashita T, Ikeda M, Yasuda I, Sugimori K, Sasahira N, Ikezawa K, Miki I, Okano N, Mizuno N, Furukawa M, Shirakawa H, Sano Y, Katayama H, Furuse J, Ueno M; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial
J Clin Oncol. 2025 Nov;43(31):3345-3354.
Murakami M, Fujimori N, Suenaga A, Ueda T, Kakehashi S, Furuta A, Ohno A, Matsumoto K, Takamatsu Y, Ueda K, Ogawa Y.
Efficacy and Safety of Duodenal Stenting for Malignant Gastric Outlet Obstruction: Insights From a 15-year Single-Center Experience
DEN Open. 2025 Aug 25;6(1):e70192.
Ogura T, Tanisaka Y, Sekine M, Kobayashi K, Maruyama H, Hirai S, Shiomi H, Shigekawa M, Kuwatani M, Ikezawa K, Itonaga M, Takenaka M, Hijioka S, Ikeura T, Doi S, Fujimori N, Koizumi K, Nakai Y, Inoue T, Mukai S, Matsumoto K, Minami R, Mandai K, Matsuda A, Iwashita T, Kawashima H, Itoi T.
Japanese Multi-Institution Study of Success Rates of Wire-Guided Biliary Cannulation During Endoscopic Retrograde Cholangiopancreatography in Relation to Guidewire tip Length (With Video)
DEN Open. 2025 Jun 16;6(1):e70144.
Koga T, Ishida Y, Hashigo S, Shimokawa Y, Harima H, Okamoto K, Ohno A, Miyagahara T, Fujita T, Fukuchi S, Takahashi K, Taguchi H, Araki N, Ohtsuka Y, Uekitani T, Tsuneyoshi K, Akiyama T, Ishigaki N, Maruo T, Saito H, Ihara R, Yamasuji A, Oe S, Yoshinari M, Sagami R, Fujimori N, Fukuda Y, Ozawa E, Jikuya K, Shinohara H, Sen-Yo M, Ueki T, Tsuchiya N, Kitaguchi T, Matsumoto K, Fukuyama M, Hirai F.
Feasibility and safety of EUS-guided biliary drainage in inexperienced centers: a multicenter study in southwest Japan
Gastrointest Endosc. 2025 Apr;101(4):843-852.e2.
Takeshita K, Hijioka S, Ikezawa K, Ogura T, Kuwatani M, Fujimori N, Doi S, Endo M, Matsubara S, Yamada R, Mashima H, Kataoka M, Takada R, Okuda A, Ohno A, Katsukura N, Suzuki H, Tanaka T, Sekine M, Kitamura H, Okusaka.
Uncovered Self Expandable Metallic Stent with an Ultra Thin Delivery Sheath in Unresectable Malignant Hilar Biliary Obstruction: A Multicenter Prospective Observational Study
Dig Dis Sci. 2025 Apr;70(4):1560-1572.
Shibuki T, Ikeda M, Yokoyama M, Sano Y, Furuse J, Kobayashi S, Ohba A, Todaka A, Horie T, Shoji K, Kanai M, Nishina T, Kumamoto Y, Fujimori N, Katanuma A, Takayama Y, Tsumura H, Miwa H, Ozaka M, Ueno M.
Depth of response in patients with locally advanced pancreatic cancer treated with first-line chemotherapy: a supplementary analysis of JCOG1407
Pancreatology. 2025 Feb 10:S1424-3903(25)00033-X.
Fujimori N, Fujita N, Murakami M, Ohno A, Matsumoto K, Teramatsu K, Ueda K, Wada N, Takao S, Okamoto D, Ishigami K, Ito T, Ogawa Y.
Usefulness of semi-automated 3D volumetric assessment of liver tumor burden for patients with unresectable pancreatic neuroendocrine tumor: A pilot study
Pancreas. 2025 Feb 1;54(2):e122-e129.
Minoda Y, Suzuki Y, Ogino H, Nagatomo S, Xiaopeng Bai, Esaki M, Wada M, Tanaka Y, Hata Y, Fujimori N, Umekita S, Tsurumaru D, Ota M, Oki E, Ihara E, Ogawa Y.
Traction-assisted endoscopic ultrasound-guided fine-needle biopsy using the clip-with-thread method for small gastric subepithelial lesions: Randomized controlled trial (with video)
Digestive Endoscopy. 2025 May;37(5):512-520.
Ikenaga N, Nakata K, Abe T, Watanabe Y, Ideno N, Murakami M, Ueda K, Fujimori N, Fujita N, Ishigami K, Ogawa Y, Nakamura M.
Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma
Surgery. 2025 Feb 178:108958.
Sano T, Kikuta K, Takikawa T, Matsumoto R, Okazaki K, Takeyama Y, Masamune A; Japan Pancreatitis Study Group for AIP (JPSG-AIP).
Serum IgG4-negative and IgG4-positive type 1 autoimmune pancreatitis present with different clinicopathological features: An analysis of a nationwide survey in Japan
Pancreatology. 2025 Feb;25(1):82-88.
Ohno A, Fujimori N, Kaku T, Matsumoto K, Murakami M, Teramatsu K, Ueda K, Hijioka M, Aso A, Ogawa Y.
Puncture angle on an endoscopic ultrasound image is independently associated with unsuccessful guidewire maniqulation of endscopic ultrasound-guided hepaticogastrostomy: a retrospective study in Japan.
Clin Endosc. 2024 Sep;57(5):656-665.
Ohno A, Fujimori N, Kaku T, Shimokawa Y, Miyagahara T, Suehiro Y, Gerodias A, Kakehashi S, Matsumoto K, Murakami M, Ueda K, Ogawa Y.
Feasibility of Endoscopic Ultrasound-Guided Hepaticogastrostomy for Malignant Hilar Biliary Obstruction
Dig Dis Sci. 2025 Jan;70(1):419-428.
Koga T, Ishida Y, Hashigo S, Shimokawa Y, Harima H, Okamoto K, Ohno A, Miyagahara T, Fujita T, Fukuchi S, Takahashi K, Taguchi H, Araki N, Ohtsuka Y, Uekitani T, Tsuneyoshi K, Akiyama T, Ishigaki N, Maruo T, Saito H, Ihara R, Yamasuji A, Oe S, Yoshinari M, Sagami R, Fujimori N, Fukuda Y, Ozawa E, Jikuya K, Shinohara H, Sen-Yo M, Ueki T, Tsuchiya N, Kitaguchi T, Matsumoto K, Fukuyama M, Hirai F.
Feasibility and safety of endoscopic ultrasound-guided biliary drainage in inexperienced centers: a multicenter study in Southwest Japan
Gastrointest Endosc. 2025 Apr;101(4):843-852.e2.
Saito T, Takenaka M, Kuwatani M, Doi S, Ohyama H, Fujisawa T, Masuda A, Iwashita T, Shiomi H, Hayashi N, Iwata K, Maruta A, Mukai T, Matsubara S, Hamada T, Inoue T, Matsumoto K, Hirose S, Fujimori N, Kashiwabara K, Kamada H, Hashimoto S, Shiratori T, Yamada R, Kogure H, Nakahara K, Ogura T, Kitano M, Yasuda I, Isayama H, Nakai Y; WONDERFUL study group in Japan and collaborators.
WONDER-02: plastic stent vs. lumen-apposing metal stent for endoscopic ultrasound-guided drainage of pancreatic pseudocysts-study protocol for a multicentre randomised non-inferiority trial.
Trials. 2024 Aug 24;25(1):559.
Ogura T, Ishiwatari H, Hijioka S, Takeshita K, Sato J, Takenaka M, Fukunaga T, Omoto S, Fujimori N, Ohno A, Hatamaru K, Tamura T, Imai H, Yamada M, Hakoda A, Nishikawa H, Kitano M.
Multicenter study comparing EUS-guided hepaticogastrostomy and ERCP for malignant biliary obstruction in patients with accessible papillae
J Hepatobiliary Pancreat Sci. 2024 Sep;31(9):680-687.
Ishiwatari H, Kawabata T, Kawashima H, Nakai Y, Miura S, Kato H, Shiomi H, Fujimori N, Ogura T, Inatomi O, Kubota K, Fujisawa T, Takenaka M, Mori H, Noguchi K, Fujii Y, Sugiura T, Ideno N, Nakafusa T, Masamune A, Isayama H, Sasahira N.
Endoscopic nasobiliary drainage versus endoscopic biliary stenting for preoperative biliary drainage in patients with malignant hilar biliary obstruction: Propensity score-matched multicenter comparative study
Dig Endosc. 2024 Jun;36(6): 726-734.
Matsumoto K, Fujimori N, Ichihara K, Takeno A, Murakami M, Ohno A, Kakehashi S, Teramatsu K, Ueda K, Nakata K, Sugahara O, Yamamoto T, Matsumoto A, Nakayama KI, Oda Y, Nakamura M, Ogawa Y.
Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction.
J Gastroenterol. 2024 Jul;59(7):629-640.
Murakami M, Fujimori N, Takamatsu Y, Ito T, Matsumoto K, Kakehashi S, Ohno A, Teramatsu K, Ueda K, Ishigami K and Ogawa Y.
Efficacy and safety of streptozocin-based chemotherapy for gastroenteropancreatic neuroendocrine tumors in Japanese clinical practice
Jpn J Clin Oncol. 2024 Jun 1;54(6):647-657.
Takikawa T, Kikuta K, Sano T, Ikeura T, Fujimori N, Umemura T, Naitoh I, Nakase H, Isayama H, Kanno A, Kamata K, Kodama Y, Inoue D, Ido A, Ueki T, Seno H, Yasuda H, Iwasaki E, Nishino T, Kubota K, Arizumi T, Tanaka A, Uchida K, Matsumoto R, Hamada S, Nakamura S, Okazaki K, Takeyama Y, Masamune A; Japan Pancreatitis Study Group for AIP.
Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan
Pancreatology. 2024 May;24(3):335-342.
Mizuno N, Ioka T, Ogawa G, Nakamura S, Hiraoka N, Ito Y, Katayama S< Takada R, Kobayashi S, Ikeda M, Muwa H, Okano N, Kuramochi H, Sekimoto M, Okusaka T, Ozaka M, Todaka A, Gotoh K, Tobimatsu K, Yamaguchi H, Nakagohri T, Kajiura S, Sudo K, Okamura K, Shimizu S, Shirakawa H, Kato N, Sano K, Iwai T, Fujimori N, Ueno M, Ishii H, Furuse J and Hepatobiliary and Pancreatic Oncology Group (HBPOG) of Japan Clinical Oncology Group (JCOG)
Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemic inflammatory response in JCOG1106
Jpn J Clin Oncol. 2023 Jul 31;53(8):704-713.
Murakami M, Fujimori N, Nakata K, Nakamura M, Hashimoto S, Kurahara H, Nishihara K, Abe T, Hashigo S, Kugiyama N, Ozawa E, Okamoto K, Ishida Y, Okano K, Takaki R, Shimamatsu Y, Ito T, Miki M, Oza N, Yamaguchi D, Yamamoto H, Takedomi H, Kawabe K, Akashi T, Miyahara K, Ohuchida J, Ogura Y, Nakashima Y, Ueki T, Ishigami K, Umakoshi H, Ueda K, Oono T, Ogawa Y.
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2
J Gastroenterol. 2023 Jun;58(6):586-597.
Ishiwatari H, Kawabata T, Kawashima H, Nakai Y, Miura S, Kato H, Shiomi H, Fujimori N, Ogura T, Inatomi O, Kubota K, Fujisawa T, Takenaka M, Mori H, Noguchi K, Fujii Y, Sugiura T, Ideno N, Nakafusa T, Masamune A, Isayama H, Sasahira N.
Clinical Outcomes of Inside Stents and Conventional Plastic Stents as Bridge-to-Surgery Options for Malignant Hilar Biliary Obstruction.
Dig Dis Sci. 2023 Apr;68(4):1139-1147.
Ozaka M, Nakachi K, Kobayashi S, Ohba A, Imaoka H, Terashima T, Ishii H, Mizusawa J, Katayama H, Kataoka T, Okusaka T, Ikeda M, Sasahira N, Miwa H, Mizukoshi E, Okano N, Mizuno N, Yamamoto T, Komatsu Y, Todaka A, Kamata K, Furukawa M, Fujimori N, Katanuma A, Takayama Y, Tsumura H, Fukuda H, Ueno M, Furuse J; Hepatobiliary and Pancreatic Oncology Group of Japan Clinical Oncology Group (JCOG).
A randomized phase Ⅱ study of modified FOLFIRINOX versus gemcitabine plusnab-paclitaxel for locally advanced pancreatic cancer (JCOG1407).
Eur J Cancer. 2023 Mar;181:135-144.
Ikenaga N, Nakata K, Abe T, Ideno N, Fujimori N, Oono T, Fujita N, Ishigami K, Nakamura M.
Risks and benefits of pancreaticoduodenectomy in patients aged 80 years and over
Langenbecks Arch Surg. 2023 Feb 27;408(1):108.
Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, Todaka A, Yanagimoto H, Morinaga S, Kobayashi S, Shimada K, Takahashi Y, Nakagohri T, Gotoh K, Kamata K, Shimizu Y, Ueno M, Ishii H, Okusaka T, Furuse J, Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial
Lancet. 2023 Jan 21; 401(10372):195-203.
Ohno A, Fujimori N, Kaku T, Takamatsu Y, Matsumoto K, Murakami M, Teramatsu K, Takeno A, Hijioka M, Kawabe K, Harada N, Nakamuta M, Aso A, Oono T, Ogawa Y.
Feasibility and Efficacy of Endoscopic Ultrasound-Guided Hepaticogastrostomy Without Dilation: A Propensity Score Matching Analysis.
Dig Dis Sci. 2022 Dec;67(12):5676-5684.
Miyagahara T, Fujimori N, Ueda K, Takamatsu Y, Matsumoto K, Teramastu K, Takaoka T, Suehiro Y, Shimokawa Y, Omori K, Niina Y, Tachibana Y, Akashi T, Oono T, Ogawa Y.
Incidence and appropriate management of drug-induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study.
Asia Pac J Clin Oncol. 2023 Aug;19(4):533-541.
Ohno A, Fujimori N, Kaku T, Hijioka M, Kawabe K, Harada N, Nakamuta M, Oono T, Ogawa Y.
The feasibility of percutaneous transhepatic gallbladder aspiration for acute cholecystitis after self-expandable metallic stent placement for malignant biliary obstruction: a 10-year retrospective analysis in a single center.
Clin Endosc. 2022 Nov;55(6):784-792.
Shibata K. Motozono C, Nagae M, Shimizu T, Ishikawa E, Motooka D, Okuzaki D, Izumi Y, Takahashi M, Fujimori N, Wing JB, Hayano T, Asai Y, Bamba T, Ogawa Y, Furutani-Seiki Makoto, Shirai M, Yamasaki S.
Symbiotic bacteria-dependent expansion of MR1-reactive T cells causes autoimmunity in the absence of Bcl11b
Nat Commun. 2022 Nov 14;13(1):6948.
Teramatsu K, Oono T, Oyama K, Fujimori N, Murakami M, Yasumori S, Ohno A, Matsumoto K, Takeno A, Nakata K, Nakamura M, Ogawa Y.
Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer
BMC Cancer. 2022 Nov 4;22(1):1134.
Miki M, Fujimori N, Ueda K, Lee L, Murakami M, Takamatsu Y, Shimokawa Y, Niina Y, Oono T, Hisano T, Furukawa M, Ogawa Y.
Treatment effect and safety of nanoliposomal irinotecan with fluorouracil and folinic acid after gemcitabine-based therapy in patients with advanced pancreatic cancer: A multicenter, prospective observational study.
J Clin Med. 2022 Aug 30;11(17):5084.
Takamatsu Y, Fujimori N, Miyagahara T, Suehiro Y, Kaku T, Kawabe K, Ohno A, Matsumoto K, Murakami M, Teramatsu K, Takeno A, Oono T, Ogawa Y.
The Glasgow Prognostic Score and stricture site can predict prognosis after endoscopic duodenal stent placement for malignant gastric outlet obstruction.
Sci Rep. 2022 Jun 13;12(1):9746.
Matsumoto K, Fujimori N, Hata Y, Minoda Y, Murakami M, Teramatsu K, Takamatsu Y, Takeno A, Oono T, Ihara E, Nakata K, Nakamura M, Yamamoto T, Koga Y, Oda Y, Ito T, Ogawa Y.
Ampullary Neuroendocrine Neoplasm: Clinicopathological Characteristics and Novel Endoscopic Entity.
Dig Dis. 2023;41(2):316-324.
Murakami M, Fujimori N, Matsumoto K, Ohno A, Teramatsu K, Takamatsu Y, Takeno A, Ueda K, Oono T, Ito T, Ogawa Y.
A clinical analysis on functioning pancreatic neuroendocrine tumors (focusing on VIPomas): a singlecenter experience.
Endocr J. 2022 Oct 28;69(10):1201-1209.
Murakami M, Fujimori N, Ohno A, Matsumoto K, Teramatsu K, Takamatsu Y, Takeno A, OonoT, Abe T, Ideno N, Ikenaga N, Nakata K, Nakamura M, Ishigami K, Ogawa Y.
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: A single-center retrospective study.
Discover Oncology, vol13(1) 2022 Jan 3;13(1):2.
Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, Nakamura K, Nakamoto Y, Hijioka S, Morita K, Ishikawa Y, Ohike N, Kasajima A, Kushima R, Kojima M, Sasano H, Hirano S, Mizuno N, Aoki T, Aoki T, Ohtsuka T, Okumura T, Kimura Y, Kudo A, Konishi T, Matsumoto I, Kobayashi N, Fujimori N, Honma Y, Morizane C, Uchino S, Horiuchi K, Yamasaki M, Matsubayashi J, Sato Y, Sekiguchi M, Abe S, Okusaka T, Kida M, Kimura W, Tanaka M, Majima Y, Jensen RT, Hirata K, Imamura M, Uemoto S.
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
J Gastroenterol. 2021 Nov;56(11):1033-1044.
Okuno H, Ogino H, Ihara E, Nishioka K, Tanaka Y, Chinen T, Kohjima M, Oono T, Tanaka M, Goya T, Fujimori N, Iboshi Y, Gotoda T, Ogawa Y.
Discriminant equation using mucosally expressed cytokines and transcription factor for making definite diagnosis of inflammatory bowel disease unclassified
BMC Gastroenterol. 2021 Feb 16;21(1):73.
Fujimori N, Osoegawa T, Aso A, Itaba S, Minoda Y, Murakami M, Matsumoto K, Teramatsu K, Takamatsu Y, Takaoka T, Oono T, Ihara E, Yoshizumi T, Ohtsuka T, Nakamura M, Ogawa Y.
Efficacy of early endoscopic ultrasound-guided transluminal drainage for postoperative pancreatic fistula.
Can J Gastroenterol Hepatol. 25;2021:6691705. eCollection 2021
Minaga K, Takenaka M, Ogura T, Tamura T, Kuroda T, Kaku T, Uenoyama Y, Noguchi C, Nishikiori H, Imai H, Sagami R, Fujimori N, Higuchi K, Kudo M, Chiba Y, Kitano M.
Endoscopic ultrasound-guided biliary drainage for malignant biliary obstruction with surgically altered anatomy: a multicenter prospective registration study.
Therap Adv Gastroenterol. 13:1-11, 2020
Ito T, Fujimori N, Honma Y, Kudo A, Hijioka S, Katsushima S, Kimura Y, Fukutomi A, Hisamatsu S, Nakajima A, Shimatsu A.
Long-term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open-label extension study.
Asia Pac J Clin Oncol. 2021 Oct;17(5):e153-e161.
Masamune A, Kikuta K, Kume K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K; Japan Pancreas Society
Nationwide epidemiological survey of chronic pancreatitis in Japan: introduction and validation of the new Japanese diagnostic criteria 2019.
J Gastroenterol. 55:1062-1071, 2020
Masamune A, Kikuta K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K; Japan Pancreas Society.
Clinical practice of acute pancreatitis in Japan: An analysis of nationwide epidemiological survey in 2016.
Pancreatology. 20:629-636, 2020
Fujimori N, Miki M, Lee L, Matsumoto K, Takamatsu Y, Takaoka T, Teramatsu K, Suehiro Y, Murakami M, Igarashi H, Oono T, Ohtsuka T, Nakamura M, Koga Y, Oda Y, Ito T, Ogawa Y.
Natural history and clinical outcomes of pancreatic neuroendocrine neoplasms based on the WHO 2017 classification; a single-center experience of 30 years.
Pancreatology. 20:709-715, 2020
Masamune A, Kikuta K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K; Collaborators.
Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016.
J Gastroenterol. 55:462-470, 2020
Fujita N, Nishie A, Asayama Y, Ishigami K, Fujimori N, Ito T, Honda H
Intravoxel incoherent motion magnetic resonance imaging for assessment of chronic pancreatitis with special focus on its early stage.
Acta Radiol. 61:579-585, 2020
Miki M, Oono T, Fujimori N, Takaoka T, Kawabe K, Miyasaka Y, Ohtsuka T, Saito D, Nakamura M, Ohkawa Y, Oda Y, Suyama M, Ito T, Ogawa Y.
CLEC3A, MMP7, and LCN2 as Novel Markers for Predicting Recurrence in Resected G1 and G2 Pancreatic Neuroendocrine Tumors.
Cancer Med. 8:3748-3760, 2019
Miyasaka Y, Ohtsuka T, Kimura R, Matsuda R, Mori Y, Nakata K, Kakihara D, Fujimori N, Ohno T, Oda Y, Nakamura M.
Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer Potentially Improves Survival and Facilitates Surgery.
Ann Surg Oncol. 26:1528-1534, 2019
Miki M, Fujimori N, Oono T, Kawabe K, Ohno A, Matsumoto K, Teramatsu K, Tachibana Y, Ogawa Y.
Relapse patterns and predictors of IgG4-related diseases involved with autoimmune pancreatitis: A single-center retrospective study of 115 patients.
J Dig Dis. 20:152-158, 2019
Toriyama K, Hijioka S, Komoto I, Kobayashi N, Okusaka T, Ku Y, Sudo K, Furukawa M, Tachibana Y, Takahashi M, Yasuda H, Nakamori S, Honma Y, Kida M, Fujimori N, Kashiwada T, Masui T, Ishii H, Tsuchiya Y, Isaji S, Mizuno N, Hara K, Sakamine M, Imamura M, Kagimura T, Ito T.
Study Protocol for Prospective Observational Study 1 on the Prognosis of Patients with Unresectable Advanced Gastrointestinal and Pancreatic Neuroendocrine Tumors (PROP-UP 1 Study) in Japan.
J Clin Trials Vol 8(4) 2018
Ohtsuka T, Gotoh Y, Nakashima Y, Okayama Y, Nakamura S, Morita M, Aly MYF, Velasquez VVDM, Mori Y, Sadakari Y, Nakata K, Miyasaka Y, Ishigami K, Fujimori N, Mochidome N, Oda Y, Shimizu S, Nakamura M.
Role of SpyGlass-DStm in the preoperative assessment of pancreatic intraductal papillary mucinous neoplasm involving the main pancreatic duct.
Pancreatology. 18; 566-571, 2018
Yasunaga K, Ito T, Miki M, Ueda K, Fujiyama T, Tachibana Y, Fujimori N, Kawabe K, Ogawa Y.
Using CRISPR/Cas9 to Knock out Amylase in Acinar Cells.
Biomed Res Int. 87:19397, 2018
Lee L, Ito T, Igarashi H, Miki M, Fujimori N, Kawabe K, Jensen RT, Ogawa Y.
Dose and schedule modification are required for long-term continuation of sunitinib in Japanese patients with advanced pancreatic neuroendocrine tumors.
Cancer Chemother Pharmacol. 81:163-169, 2018
Ueda K, Kawabe K, Lee L, Tachibana Y, Fujimori N, Igarashi H, Oda Y, Jensen RT, Takayanagi R, Ito T.
Diagnostic Performance of 48-Hour Fasting Test and Insulin Surrogates in Patients With Suspected Insulinoma.
Pancreas. 46:476-481, 2017
Niina Y, Ito T, Ueda K, Lee L, Igarashi H, Hijioka M, Takaoka T, Fujiyama T, Miki M, Tachibana Y, Fujimori N, Ohtsuka T, Nakamura K, Kawabe K, Ogawa Y.
Effectiveness of endoscopic duodenal stenting for the management of patients with unresectable pancreatic cancer.
Gastroenterol Hepatol Endosc, 2:1-5, 2017
Ito T, Ishiguro H, Ohara H, Kamisawa T, Sakagami J, Sata N, Takeyama Y, Hirota M, Miyakawa H, Igarashi H, Lee L, Fujiyama T, Hijioka M, Ueda K, Tachibana Y, Sogame Y, Yasuda H, Kato R, Kataoka K, Shiratori K, Sugiyama M, Okazaki K, Kawa S, Tando Y, Kinoshita Y, Watanabe M, Shimosegawa T.
Evidence-based Clinical Practice Guidelines for Chronic Pancreatitis 2015.
J Gastroenterol 51: 85-92, 2016
Nakamura K, Osada M, Iwasa T, Takahashi S, Takizawa N, Akahoshi K, Ochiai T, Nakamura N, Akiho H, Itaba S, Harada N, Iju M, Tanaka M, Kubo H, Somada S, Ihara E, Oda Y, Ito T, Takayanagi R.
Short- and long-term outcomes of endoscopic resection of rectal neuroendocrinetumors: analyses according to the WHO 2010 classification.
Scand J Gastroenterol 51: 448-455, 2016
Notohara K, Nishimori I, Mizuno N, Okazaki K, Ito T, Kawa S, Egawa S, Kihara Y, Kanno A, Masamune A, Shimosegaw T.
Clinicopathological Features of Type 2 Autoimmune Pancreatitis in Japan: Results of a Multicenter Survey.
Pancreas. 44: 1072-1077, 2015
Kawa S, Okazaki K, Notohara K, Ueki T, Matsui T, Kanno A, Watanabe T, Uchida K, Taguchi M, Igarashi H, Ito T, Igarashi H, Kawanobe T, Iijima H, Kohgo Y, Ito T, Kunisaki R, Nagahori M, Itoi T, Honjo M, Sakagami J, Yasuda H, Hatakeyama K, Iiai T, Hirooka Y, Sumi H, Watanabe K, Sasaki M, Ando A, Inatomi O, Kinjo F, Iraha A, Fujita N, Masu K, Kagaya T, Miyakawa H, Okamura K, Hibi N, Nakamura Y, Fukuda K, Ikeura T, Ishikawa T, Ueno F, Satoh A, Uemura M, Tsubouchi H, Funakawa K, Iizuka M, Yoden A, Kubota K, Funayama Y, Eguchi T, Ishigro Y, Uehara N, Arakura N, Kamisawa T, Nishimori I, Ohara H, Mizuno N, Hirano K, Masamune A, Kikuta K, Watanabe M, Shimosegawa T.
Autoimmune Pancreatitis Complicated with Inflammatory Bowel Disease and
Comparative Study of Type 1 and Type 2 Autoimmune Pancreatitis.
J Gastroenterol. 50: 805-815, 2015
Watanabe Y, Ohtsuka T, Matsunaga T, Kimura H, Tamura K, Ideno N, Aso T, Miyasaka Y, Ueda J, Takahata S, Igarashi H, Inoguchi T, Ito T, Tanaka M.
Long-Term Outcomes After Total Pancreatectomy: Special Reference to Survivors' Living Conditions and Quality of Life.
World J Surg. 39: 1231-1239, 2015
Ito T, Igarashi H, Nakamura K, Sasano H, Okusaka T, Yakano K, Komoto I, Tanaka M, Imamura M, Jensen RT, Takayanagi R, Shimatsu A.
Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis.
J Gastroenterol.50: 58-64, 2015
Aoki T, Kokudo N, Komoto I, Takaori K, Kimura W, Sano K, Takamoto T, Hashimoto T, Okusaka T, Morizane C, Ito T, Imamura M.
Streptozocin chemotherapy for advanced/metastatic well-differentiated neuroendocrine tumors: an analysis of multi-center survey in Japan.
J Gastroenterol. 50: 769-775, 2015
Ito T, Lee L, Hijioka M, Kawabe K, Kato M, Nakamura K, Ueda K, Ohtsuka T, Igarashi H.
The up-to-date review of epidemiological pancreatic neuroendocrine tumors in Japan.
J Hepatobiliary Pancreat Sci. 22: 574-547, 2015
Igarashi H, Hijioka M, Lee L, Ito T.
Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs.
J Hepatobiliary Pancreat Sci. 22: 618-622, 2015
Lee L, Igarashi H, Fujimori N, Hijioka M, Kawabe K, Oda Y, Jensen RT, Ito T.
Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine tumors:a single-center retrospective study.
Jpn J Clin Oncol. 45: 1131-1138, 2015
Hijioka M, Ito T, Igarashi H, Fujimori N, Lee L, Nakamura T, Jensen RT, Takayanagi R.
Serum Chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumor.
Cancer Sci. 105: 1464-1471, 2014
Niina Y, Ito T, Oono T, Nakamura T, Fujimori N, Igarashi H, Sakai Y, Takayanagi R.
A sustained prostacyclin analog, ONO-1301, attenuates pancreatic fibrosis in experimental chronic pancreatitis induced by dibutyltin dichloride in rats.
Pancreatology. 14:201-10. 2014
Ohtsuka T, Tamura K, Ideno N, Aso T, Nagayoshi Y, Kono H, Ueda J, Takahata S, Aso A, Igarashi H, Ito T, Ushijima Y, Ookubo F, Oda Y, Mizumoto K, Tanaka M.
The role of ERCP in the era of EUS-FNA for preoperative cytological confirmation of resectable pancreatic ductal adenocarcinoma.
Surg Today. 44: 1887-1892, 2014
Kamisawa T, Okazaki T, Kawa S, Shimosegawa T, Tanaka M, Nishimori I, Ito T, Tanaka S, and Working members of Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society.
Amendment of Japanese Consensus Guideline for Management of Autoimmune Pancreatitis,2013. III. Treatment and prognosis of AIP.
J Gastroenterol. 49: 961-970, 2014
Kawa S, Okazaki K, Kamisawa T, Kubo K, Ohara H, Hasebe O, Fujinaga Y, Irisawa A, Notohara K, Ito T, Inui K, Irie H, Nishino T, Nishimori I, Tanaka S, Nishiyama T, MD, Suda K, Shiratori K, Tanaka M, Shimosegawa T.
Amendment of Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013.II. Extra-pancreatic lesions, differential diagnosis.
J Gastroenterol. 49: 765-784, 2014
Okazaki T, Kawa S, Kamisawa T, Ito T, Inui K, Irie H, Nishino T, Notohara K, Nishimori I, Tanaka S, Nishiyama T, Suda K, Shiratori K, Tanaka M, Shimosegawa T, and Working members of Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society.
Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013.I. Concept and diagnosis of autoimmune pancreatitis.
J Gastroenterol. 49: 567-588, 2014
Uchida M, Ito T, Nakamura T, Hijioka M, Igarashi H, Oono T, Kato M, Nakamura K, Suzuki K, Takayanagi R, Jensen RT.
Pancreatic stellate cells and CX3CR1: occurrence in normal pancreas, acute and chronic pancreatitis and effect of their activation by a CX3CR1 agonist.
Pancreas. 43: 708-719, 2014
Ishigami K, Nishie A, Asayama Y, Ushijima Y, Takayama Y, Fujita N, Takahata S, Ohtsuka T, Ito T, Igarashi H, Ikari S, Metz CM, Honda H.
Imaging pitfalls of pancreatic serous cystic neoplasm and its potential mimickers.
World J Radiol. 6: 36-47, 2014
Nagayoshi Y, Aso T, Ohtsuka T, Kono H, Ideno N, Igarashi H, Takahata S, Oda Y, Ito T, Tanaka M.
Peroral pancreatoscopy using the SpyGlass system for the assessment of Intraductal papillary mucinous neoplasm of the pancreas.
J Hepatobiliary Pancreat Sci. 21: 410-417, 2014
Aso A, Ihara E, Osoegawa T, Nakamura K, Itaba S, Igarashi H, Ito T, Aishima S, Oda Y, Tanaka M, Takayanagi R.
Key Endoscopic Ultrasound Features of Pancreatic Ductal Adenocarcinoma Smaller than 20 mm.
Scand J Gastroenterol. 49: 332-338, 2014
Nagayoshi Y, Nakamura M, Matsuoka K, Ohtsuka T, Mori Y, Kono H, Aso T, Ideno N, Takahata S, Ryo A, Takeda H, Ito T, Oda Y, Endo Y, Sawasaki T, Tanaka M.
Profiling of autoantibodies in sera of pancreatic cancer patients.
Ann Surg Oncol. 21: 459-465, 2014
Nakamura T, Ito T, Uchida M, Hijioka M, Igarashi H, Oono T, Kato M, Nakamura K, Suzuki K, Jensen RT, Takayanagi R.
PSCs and GLP-1R: occurrence in normal pancreas, acute/chronic pancreatitis and effect of their activation by a GLP-1R agonist.
Lab Invest. 94: 63-78, 2014
Igarashi H, Ito T, Nishimori I, Yamasaki I, Shuin T.
Pancreatic involvement in Japanese patients with von Hippel-Lindau disease: results of a nationwide survey.
J Gastroenterol. 49: 511-516, 2014
Fujimori N, Igarashi H, Asou A, Kawabe K, Lee L, Oono T, Nakamura T, Niina Y, Hijioka M, Uchida M, Kotoh K, Nakamura K, Ito T, Takayanagi R.
Endoscopic approach through the minor papilla in the management of pancreatic diseases.
World J Gastrointest Endosc. 5: 81-88, 2013
Uchida M, Ito T, Nakamura T, Igarashi H, Oono T, Fujimori N, Kawabe K, Suzuki K, Jensen RT, Takayanagi R.
ERK pathway and sheddases play an essential role in ethanol-induced CX3CL1 release in pancreatic stellate cells.
Lab Invest.93:41-53, 2013
Otsuki M, Takeda K, Matsuno S, Kihara Y, Koizumi M, Hirota M, Ito T, Kataoka K, Kitagawa M, Inui K, Takeyama Y.
Criteria for the diagnosis and severity stratification of acute pancreatitis.
World J Gastroenterol. 19: 5798-5805, 2013
Ohtsuka T, Ideno N, Aso T, Nagayoshi Y, Kono H, Mori Y, Takahata S, Oda Y, Aishima S, Igarashi H, Ito T, Ishigami K, Nakamura M, Mizumoto K, Tanaka M.
Role of endoscopic retrograde pancreatography for early detection of Pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas.
J Hepatobiliary Pancreat Sci. 20: 356-361, 2013
Ito T, Okusaka T, Nishida T, Igarashi H, Mizuno N, Hara K, Morizane C, Kondo S, Hashigaki S, Kimura N, Okano K, Tanuma J, Murakami M, Sawaki A, Yamao K, Imamura M.
Phase II Study of Sunitinib in Japanese Patients with Unresectable or Metastatic, Well-differentiated Pancreatic Neuroendocrine Tumor.
Invest New Drugs. 31: 1265-1274, 2013
Ito T, Igarashi H, Uehara H, Berma MJ, Jense RT.
Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1 With Pancreatic Endocrine Tumor and Zollinger-Ellison Syndrome: Prospective Study of 106 Cases and Review of the Literature.
Medicine (Baltimore). 92: 135-181, 2013
Nakamura T, Ito T, Igarashi H, Uchida M, Hijioka M, Oono T, Fujimori N, Niina Y, Suzuki K, Jensen RT, Takayanagi R.
Cytosolic double-stranded DNA as a damage-associated molecular pattern induces the inflammatory response in rat pancreatic stellate cells: a plausible mechanism for tissue injury-associated pancreatitis.
Int J Inflam.2:504128. 2012
Igarashi H, Ito T, Oono T, Nakamura T, Fujimori N, Niina Y, Hijioka M, Uchida M, Lee R, Iwao R, Nakamura K, Kotoh K, Takayanagi R.
Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases.
J Dig Dis.13:274-9, 2012
Ohtsuka T, Kono H, Tanabe R, Nagayoshi Y, Mori Y, Sadakari Y, Takahata S, Oda Y, Aishima S, Igarashi H, Ito T, Ishigami K, Nakamura M, Mizumoto K, Tanaka M.
Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas.
Am J Surg. 204: 44-48, 2012
Nakamura T, Ito T, Suzuki K, Uchida M, Igarashi H, Jensen RT, Takayanagi R.
Cytosolic double-stranded DNA as damage-associated molecular-patters induced inflammatory responses in rat pancreatic stellate cells ~ plausible mechanism for tissue-injury associated pancreatitis.
Int J Inflam. 2012: 504128, 2012
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui K, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H for the All Japan IgG4 team.
Comprehensive Diagnostic Criteria (CDC criteria) for IgG4-related disease(IgG4-RD), 2011.
Mod Rheumatol. 22: 21-30, 2012
Tsutsumi K, Ohtsuka T, Mori Y, Fujino M, Yasui T, Aishima S, Takahata S, Nakamura M, Ito T, Tanaka M.
Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.
J Gastroenterol. 47: 678-685, 2012
Ito T, Okusaka T, Ikeda M, Igarashi H, Morizane C, Nakachi K, Tajima T, Kasuga A, Fujita Y, Furuse J.
Everolimus for Advanced Pancreatic Neuroendocrine Tumors: A Subgroup Analysis Evaluating Japanese Patients in the RADIANT-3 Trial.
Jpn J Clin Oncol. 42: 903-911, 2012
Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EG, Tomassetti P, Pavel ME, Hoosen S, Haas T, Lincy J, Lebwohl D, Öberg K.
RAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study Group.
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
N Engl J Med. 364: 514-523, 2011
Okusaka T, Furuse J, Funakoshi A, Ioka T, Yamao K, Ohkawa S, Boku N, Komatsu Y, Nakamori S, Iguchi H, Ito T, Nakagawa K, Nakachi K.
Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer.
Cancer Sci. 102: 425-443, 2011
Fujimori N, Oono T, Igarashi H, Ito T, Nakamura T, Uchida M, Coy DH, Jensen RT, Takayanagi R.
Vasoactive intestinal peptide reduces oxidative stress in pancreatic acinar cells through the inhibition of NADPH oxidase.
Peptides. 32:2067-76, 2011
Nakamura T, Ito T, Oono T, Igarashi H, Fujimori N, Uchida M, Niina Y, Yasuda M, Suzuki K, Takayanagi R.
Bacterial DNA promotes proliferation of rat pancreatic stellate cells thorough toll-like receptor 9: potential mechanisms for bacterially induced fibrosis.
Pancreas. 40:823-31, 2011
Ito T, Nakamura T, Fujimori N, Niina Y, Igarashi H, Oono T, Uchida M, Kawabe K, Takayanagi R, Nishimori I, Otsuki M, Shimosegawa T.
Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis.
J Dig Dis. 12:210-6, 2011
Ito T, Sasano H, Tanaka M, Osamura RY, Sasaki I, Kimura W, Takano K, Obara T, Ishibashi M, Nakao K, Doi R, Shimatsu A, Nishida T, Komoto I, Hirata Y, Nakamura K, Igarashi H, Jensen RT, Wiedenmann B, Imamura M.
Epidemiological Study of Gastroenteropancreatic Neuroendocrine Tumors in Japan.
J Gastroenterol. 45: 234-243, 2010
Ito T, Otsuki M, Igarashi H, Kihara Y, Kawabe K, Nakamura T, Fujimori N, Oono T, Takayanagi R, Shimosegawa T.
Epidemiological Study of Pancreatic Diabetes in Japan in 2005: A Nationwide Study.
Pancreas. 39:829-835, 2010
著書・総説
藤森 尚、末永 顕彦、上田 孝洋、梯 祥太郎、大野 彰久、安森 翔、松本 一秀、村上 正俊、植田 圭二郎、小川 佳宏
【膵外分泌機能不全を再考する】
膵外分泌機能不全の原因と病態 慢性膵炎における膵外分泌機能不全
肝胆膵 90(2); 157-163, 2025.2
藤森 尚、末永 顕彦、川口 夢佳、赤木 健哉、上田 孝洋、梯 祥太郎、安森 翔、大野 彰久、松本 一秀、村上 正俊、植田 圭二郎、伊藤 鉄英、小川 佳宏
【膵外分泌機能不全を究める】
膵外分泌機能不全に伴う糖尿病の病態と治療
胆と膵 46(1); 55-60, 2025.1
高松 悠、伊藤 鉄英、三船 繭子、平賀 ちひろ、新名 雄介、岡本 亮子、植田 圭二郎、藤岡 真之、藤山 隆、藤森 尚
【膵外分泌機能不全を究める】
膵外分泌機能不全に対する栄養サポート
胆と膵 46(1); 61-64, 2025.01
村上 正俊、藤森 尚、宮ケ原 典、赤木 健哉、川口 夢佳、末永 顕彦、上田 孝洋、梯 祥太郎、大野 彰久、松本 一秀、植田 圭二郎、小川 佳宏
【希少領域、治療困難例における膵・胆道癌の薬物療法】
治療困難な膵・胆道癌の薬物療法 閉塞性・拘束性肺障害合併胆道癌・膵癌の薬物療法および薬剤性肺障害について
胆と膵 45(11); 1669-1675, 2024.11
藤森 尚、赤木 健哉、川口 夢佳、末永 顕彦、Gerodias Anthony R.、上田 孝洋、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、植田 圭二郎、小川 佳宏
【胆膵Interventional Endoscopyを極める】
トラブルシューティング 膵管ステント迷入
胆と膵 45(臨増特大); 1377-1383, 2024.10
藤森 尚、小森 康寛、末永 顕彦、植田 圭二郎、小川 佳宏
【スキルアップ内視鏡診療】胆膵 挿管・診断
経口胆道鏡をマスターする
消化器内視鏡 36(増刊号); 343-347, 2024.10
伊藤 鉄英、高松 悠、植田 圭二郎、村上 正俊、松本 一秀、藤森 尚
【膵胆道周囲の後腹膜腫瘍性病変の診断と治療】
膵胆道周囲の後腹膜腫瘍性病変 ～膵神経内分泌腫瘍～
胆と膵 45(9); 915-920, 2024.9
松本 一秀、藤森 尚、上田 孝洋、梯 祥太郎、大野 彰久、村上 正俊、植田 圭二郎、小川 佳宏
【今推しの肝胆膵研究手法と疾患モデル】
新規モデルによる肝胆膵研究 膵臓癌オルガノイドを用いたサブタイプ予測による予後解析
肝胆膵 89(2); 243-248, 2024.8
松本 一秀、藤森 尚、小川 佳宏
オルガノイド研究で膵がん治療を革新したい
国際医薬品情報 1255; 22-23, 2024.8
大野 彰久、藤森 尚、小森 康寛、末永 顕彦、梯 祥太郎、松本 一秀、村上 正俊、寺松 克人、植田 圭二郎、小川 佳宏
【日常診療での超音波検査のおさえどころ】
超音波検査の最新の進歩 胆膵のInterventional EUS
臨牀と研究 101(7); 58-59, 2024.7
松本 一秀、藤森 尚、末永 顕彦、小森 康寛、梯 祥太郎、大野 彰久、村上 正俊、寺松 克人、植田 圭二郎、小川 佳宏
当院における超音波内視鏡下膵管ドレナージ（EUS-PD）の治療成績
膵臓 39(3); A438, 2024.7
大野 彰久、小森 康寛、梯 祥太郎、松本 一秀、村上 正俊、寺松 克人、植田 圭二郎、藤森 尚
膵腫瘤に対するEUSガイド下組織採取（ERS-TA）における再穿刺の意義
膵臓 39(3); A422, 2024.7
植田 圭二郎、高松 悠、藤森 尚、伊藤 鉄英、河村 康平、小森 康寛、末永 顕彦、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、寺松 克人、小川 佳宏
肝転移を伴った膵神経内分泌腫瘍の治療戦略 肝転移を伴う膵神経内分泌腫瘍におけるペプチド受容体核医学内用療法（PRRT）
膵臓 39(3); A225, 2024.7
藤森 尚（回答者）、松本 和幸（質問者；岡山大学病院消化器内科）
小径かつ低悪性度の膵神経内分泌腫瘍に対して経過観察した場合のデータは？経過観察は許容される？
週刊 日本医事新報 No.5215; 50-51, 2024.4
大野 彰久、小森 康寛、末永 顕彦、梯 祥太郎、松本 一秀、村上 正俊、植田 圭二郎、加来 豊馬、藤森 尚
【超音波診断装置を用いたインターベンションにおける合併症予防とトラブルシューティング】
安全で確実なEUS―HGSを目指して ガイドワイヤーの観点から
超音波医学 51; S227, 2024.4
藤森 尚、村上 正俊、松本 一秀、大野 彰久、寺松 克人、植田 圭二郎、伊藤 鉄英、小川 佳宏
【超高齢社会（高齢化率21％以上）の膵疾患診療】
超高齢社会における膵神経内分泌腫瘍診断療
膵臓 39; 33-42, 2024.2
村上 正俊、藤森 尚、末永 顕彦、小森 康寛、梯 祥太郎、大野 彰久、松本 一秀、寺松 克人、植田 圭二郎、伊藤 鉄英、小川 佳宏.
【神経内分泌腫瘍の新たな知見〜膵消化管神経内分泌腫瘍診療ガイドライン改定に向けて〜】
膵・消化管神経内分泌腫瘍におけるliquid biopsy診断.
胆と膵 45; 25-31, 2024.1
藤森 尚、村上 正俊、蓑田 洋介、植田 圭二郎、伊藤 鉄英、小川 佳宏
【神経内分泌腫瘍の新たな知見〜膵消化管神経内分泌腫瘍診療ガイドライン改定に向けて〜】
AIを用いた膵神経内分泌腫瘍治療切除後再発予測モデルの構築と分析
胆と膵 45; 85-93, 2024.1
藤森 尚、小森 康寛、末永 顕彦、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、寺松 克人、植田 圭二郎、伊藤 心二、吉住 朋晴、池永 直樹、仲田 興平、中村 雅史、小川 佳宏
術後膵液瘻に対するStenting Strategy
胆と膵 44(臨時増刊号); 1215-1221, 2023
Fujimori N, Ito T, Ogawa Y.
Diabetes from Exocrine Pancreatic Disease.
Chapter 56, Section 4 : Chronic Pancreatitis
The Pancreas; 445-450, 2023
Ito T, Ueda K, Fujimori N, Jensen RT.
Clinical Manifestation of Endocrine Tumors of the Pancreas.
Chapter 102, Section 7 : Neoplastic Tumors of the Endocrine Pancreas
The Pancreas; 791-798, 2023
Ueda K, Fujimori N, Jensen RT, Ito T.
The Management of Insulinoma.
Chapter 112, Section 7 : Neoplastic Tumors of the Endocrine Pancreas
The Pancreas; 865-871, 2023
大野 彰久、藤森 尚、寺松 克人、植田 圭二郎、小川 佳宏
【特集 胆膵の画像・内視鏡診断の進歩―早期診断と正確な診断のために】
慢性膵炎の画像診断の進歩
臨牀消化器内科 38(13); 1632-1639, 2023.11
藤森 尚、小森 康寛、末永 顕彦、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、寺松 克人、植田 圭二郎、伊藤 心二、吉住 朋晴、池永 直樹、仲田 興平、中村 雅史、小川 佳宏
炎症・体液貯留に対するStenting Strategy 術後膵液瘻に対するStenting Strategy.
胆と膵 44(臨増特大); 1215-1221, 2023.10
植田 圭二郎、伊藤 鉄英、河村 康平、小森 康寛、末永 顕彦、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、寺松 克人、藤森 尚、小川 佳宏
【特集 胆道癌と膵癌のリスクファクター】
飲酒と発がん
胆と膵 44(9); 815-819, 2023.9
植田 圭二郎、藤森 尚
膵癌患者における糖尿病
胆膵の病態生理 39(1); 37, 2023.6
伊藤 鉄英、高松 悠、渡邉 洋子、植田 圭二郎、永田 宙生、平松 真祐、白石 素公、矢永 勝彦、恒吉 正澄
膵神経内分泌腫瘍と代謝異常
胆と膵 44(5); 453-458, 2023.5
村上 正俊、藤森 尚、小森 康寛、木村 弥成子、大野 彰久、松本 一秀、寺松 克人、植田 圭二郎、伊藤 鉄英、小川 佳宏
ランレオチドによる膵NETに対する抗腫瘍治療
胆と膵 44(1); 53-59, 2023.1
藤森 尚、大野 彰久、植田 圭二郎、蓑田 洋介、小川 佳宏
治療的EUS Peripancreatic/pancreatic fluid collection(PFD)ドレナージ ステントが迷入してしまった
消化器内視鏡 34(12); 1976-1980, 2022.12
藤森 尚、小川 佳宏
慢性膵炎の患者にはどのような生活指導が必要でしょうか？
内科 130(3); 502-505, 2022.9
藤森 尚、松本 一秀、寺松 克人、竹野 歩、小川 佳宏
胆膵疾患の総ざらい 慢性膵炎
内科 130(1); 77-83, 2022.7
村上 正俊、藤森 尚、小森 康寛、木村 弥成子、大野 彰久、松本 一秀、寺松 克人、竹野 歩、植田 圭二郎、伊藤 鉄英、小川 佳宏
膵神経内分泌腫瘍のリキッドバイオプシー
肝胆膵 84(6); 745-750, 2022.6
藤森 尚、大野 彰久、松本 一秀、村上 正俊、寺松 克人、竹野 歩、大野 隆真、小川 佳宏
膵臓の画像診断（CT・MRI・超音波内視鏡）
Medical Technology 50(5); 481-487, 2022.5
村上 正俊、藤森 尚、上田 孝洋、大野 彰久、松本 一秀、寺松 克人、高松 悠、竹野 歩、大野 隆真、伊藤 鉄英、小川 佳宏
膵神経内分泌腫瘍におけるLiquid biopsy診断と治療への応用
胆と膵 43(2); 141-145, 2022.2
藤森 尚、寺松 克人、高松 悠、上田 孝洋、平畠 啓介、大野 彰久、村上 正俊、安森 翔、松本 一秀、竹野 歩、大野 隆真、小川 佳宏.
Liquid biopsyの膵癌切除後のサーベイランスへの応用
胆と膵 43(1); 71-75, 2022.1
松本 一秀、藤森 尚、蓑田 洋介、原 真児登、梯 祥太郎、安森 翔、村上 正俊、寺松 克人、高松 悠、長友 周三郎、西岡 慧、小森 圭司、日置 智惟、川元 美緒、大野 隆真、伊原 栄吉、国府島 庸之、小川 佳宏
膵癌患者由来オルガノイド樹立におけるEUS-FNABと経皮的肝腫瘍生検の有用性の検討（第一報）
日本消化器病学会雑誌 118（臨増大会）; A728, 2021.10
村上 正俊、藤森 尚、梯 祥太郎、松本 一秀、安森 翔、寺松 克人、高松 悠、大野 隆真、小川 佳宏、井出野 昇、森泰寿、池永 直樹、仲田 興平、中村 雅史
当院における膵癌術前化学療法（NAC）無効例の検討
日本消化器病学会雑誌 118（臨増大会）; A760, 2021.10
藤森 尚
慢性膵炎に伴う糖尿病および合併症（治療3）
膵臓 36(3); A112, 2021.8
村上 正俊、藤森 尚、梯 祥太郎、松本 一秀、安森 翔、寺松 克人、高松 悠、大野 隆真、伊藤 鉄英
膵神経内分泌腫瘍の集学的治療 当科における転移性/切除不能膵神経内分泌腫瘍に対する治療戦略
膵臓 36(3); A154, 2021.8
藤森 尚、安森 翔、村上 正俊、松本 一秀、寺松 克人、高松 悠、大野 隆真、伊藤 心二、沖田 興平、中村 雅史
膵癌治療（ステント）膵頭十二指腸切除後膵液漏に対するEUS下膵管ドレナージ 新たな適応の可能性
膵臓 36(3); A295, 2021.8
寺松 克人、大野 隆真、松本 一秀、村上 正俊、高松 悠、竹野 歩、藤森 尚、安森 翔、原 真児登、梯 祥太郎、大野 彰久
末梢血リンパ球亜型と膵癌予後との検討
膵臓 36(3); A301, 2021.8
藤森 尚、村上 正俊、松本 一秀、寺松 克人、高松 悠、竹野 歩、原 真児登、梯 祥太郎、 安森 翔、大野 隆真
膵・消化管神経内分泌腫瘍を巡る最近の話題 NEN診断と治療の新時代 膵・消化管神経内分泌腫瘍(GEP-NEN)の診断の進歩
Pharma Medica 39(5); 66-72, 2021.5
高松 悠、藤森 尚、河邉 顕
消化管狭窄に対する内視鏡治療の現状と課題 悪性胃十二指腸狭窄に対する内視鏡的十二指腸ステント留置術の有用性と予後因子に関する多施設後方視的研究
Gastroenterological Endscopy 63(Suppl.); 772, 2021.4
藤森 尚、蓑田 洋介、大野 隆真
小児に対する内視鏡診療 全身麻酔下超音波内視鏡下穿刺吸引法（EUS-FNA）が治療方針決定に有用であった小児膵腫瘍の2例 小児におけるEUS-FNAの位置付け
Gastroenterological Endscopy 63(Suppl.); 835, 2021.4
安森 翔、村上 正俊、藤森 尚、梯 祥太郎、原 真児登、松本 一秀、寺松 克人、高松 悠、日置 智惟、川元 美緒、大野 隆真
生体肝移植後症例における胆管プラスチックステント迷入のトラブルシューティング
Gastroenterological Endscopy 63(Suppl.); 907, 2021.4
藤森 尚、大野 隆真、中村 雅史
慢性膵炎を巡る諸問題：早期慢性膵炎から外科治療まで 慢性膵炎の経過観察はいつまで必要か？小膵石診断8年後に切除可能膵癌を発症した症例から
日本消化器病学会雑誌 118(臨増大会); A125, 2021.3
藤森 尚、原 真児登、梯 祥太郎、安森 翔、村上 正俊、松本 一秀、寺松 克人、高松 悠、竹野 歩、大野 隆真、伊藤 鉄英、小川 佳宏
慢性膵炎に対する薬物治療
胆と膵 42(2); 113-116, 2021.2
松本 一秀、藤森 尚、末廣 侑大、村上 正俊、寺松 克人、高松 悠、高岡 雄大、大野 隆真、五十嵐 久人、伊藤 鉄英
内科的加療で低血糖を制御し得た高齢発症悪性インスリノーマの一例
膵臓 35(5); 429-438, 2020.10
藤森 尚、高松 悠、松本 一秀、寺松 克人、大野 隆真、小川 佳宏
慢性膵炎の病態（1）成因、疫学
臨床消化器内科 35(11); 1297-1302, 2020.9
植田 圭二郎、下川 雄三、中村 聡、小薗 真吾、空閑 啓髙、西原 一善、藤森 尚、大野 隆真
切除不能膵癌のGnP療法憎悪後生存期間における腫瘍増大パターン・後治療の検討
膵臓 35(3), A321, 2020.7
藤森 尚、松本 一秀、村上 正俊、加来 豊馬、末廣 侑大、寺松 克人、高松 悠、高岡 雄大、大野 隆真、五十嵐 久人、森 泰寿、大塚 隆生、小川 佳宏
胆膵疾患における緊急内視鏡～リスクマネジメントも含めて～. EST後出血（抗血栓薬内服例も含めて）
胆と膵 41(2); 175-181, 2020.7
藤森 尚、末廣 侑大、村上 正俊、松本 一秀、寺松 克人、高松 悠、高岡 雄大、大野 真隆
膵周囲液体貯留に対するlumen-apposing metal stentの治療成績と偶発症
膵臓 35(3), A364, 2020.7
藤森 尚、村上 正俊、末廣 侑大、松本 一秀、寺松 克人、高松 悠、高岡 雄大、竹野 歩、大野 隆真、小川 佳宏
膵癌の日常診療－診断の進め方
臨床と研究 97(5); 537-542, 2020.5
高松 悠、大野 隆真、末廣 侑大、村上 正俊、松本 一秀、寺松 克人、高岡 雄大、藤森 尚、上田 詩織、本坂亜希子、吉澤 裕子、南 晴奈、上野 寿弥、國栖 真理、横山 富美子、盛永 彩香、花田 浩和、濵﨑 正子
慢性膵炎患者に対する多職種連携のサポーティブ・ケアの試み
膵臓 35(2); 180-186, 2020.4
藤森 尚、末廣 侑大、村上 正俊、松本 一秀、寺松 克人、高松 悠、高岡 雄大、大野 隆真、五十嵐 久人、伊藤 鉄英、小川 佳宏
喫煙と慢性膵炎の関係－基礎研究と疫学調査のデータから－
肝胆膵 80(2); 259-263, 2020.2
藤森 尚、松本 一秀、村上 正俊、加来 豊馬、末廣 侑大、寺松 克人、高松 悠、高岡 雄大、大野 隆真、五十嵐 久人、森 泰寿、大塚 隆生、小川 佳宏
胆膵疾患における緊急内視鏡～リスクマネジメントも含めて～. EST後出血（抗血栓薬内服例も含めて）.
胆と膵 41; 175-181, 2020.2
藤森 尚、末廣 侑大、村上 正俊、松本 一秀、寺松 克人、高松 悠、高岡 雄大、大野 隆真、松田 やよい、坂本 竜一、五十嵐 久人、伊藤 鉄英、小川 佳宏
【膵炎大全Ⅱ～膵炎・Up to date～】膵炎の治療 膵性糖尿病の診断と治療
胆と膵 40(臨増特大); 1179-1183, 2019.11
植田 圭二郎、下川 雄三、秋穂 裕唯、藤森 尚、大野 隆真、伊藤 鉄英
【膵炎大全II～膵炎・Up to date～】膵炎の診断方法 膵炎における膵内分泌検査(解説/特集)
胆と膵 40(臨増特大); 1133-1137, 2019.11
肱岡 真之、大野 彰久、加来 豊馬、藤森 尚、大野 隆真、河邉 顕、伊藤 鉄英
【膵炎大全II～膵炎・Up to date～】膵炎の治療 膵炎に対する生活指導および栄養療法の留意点(解説/特集)
胆と膵 40 (臨増特大); 1173-1177, 2019.11
三木 正美、大野 隆真、藤森 尚、李 倫學、伊藤 鉄英
【膵炎大全II～膵炎・Up to date～】膵炎各論 虚血性膵炎(解説/特集)
胆と膵 40 (臨増特大); 1241-1245, 2019.11
藤森 尚、松本 一秀、三木 正美、寺松 克人、高松 悠、高岡 雄大、村上 正俊、末廣 侑大、大野 隆真、荻野 治栄、伊原 栄吉、五十嵐 久人、古賀 裕、伊藤 鉄英、小川 佳宏
膵・消化管神経内分泌腫瘍画像診断のコツと生検の意義
臨床外科 74(9); 1042-1050, 2019.9
藤森 尚、伊藤 鉄英、大野 彰久、松本 一秀、寺松 克人、高松 悠、三木 正美、高岡 雄大、大野 隆真、小川 佳宏
【内視鏡分類2019】胆・膵 膵癌・膵神経内分泌腫瘍 膵嚢胞性腫瘍を除いて
消化器内視鏡 31(4); 676-682, 2019.4
藤森 尚、伊藤 鉄英、大野 彰久、松本 一秀、寺松 克人、高松 悠、三木 正美、高岡 雄大、大野隆真、小川 佳宏
膵癌・膵神経内分泌腫瘍（膵嚢胞性腫瘍除く）
消化器内視鏡 31; 676-682, 2019.4
藤森 尚、伊藤 鉄英、三木 正美、大野 彰久、松本 一秀、寺松 克人、高松 悠、高岡 雄大、大野 隆真、五十嵐 久人、小川 佳宏
膵・消化管神経内分泌腫瘍の切除不能肝転移に対する局所療法
胆と膵 40(2); 161-165, 2019.2
伊藤 鉄英、李 倫学、藤森 尚
【膵神経内分泌腫瘍-診断と治療のパラダイムシフト-】薬物治療 膵神経内分泌腫瘍(NET)の薬剤選択
肝胆膵 78(1); 87-92, 2019.1
三木正美、伊藤鉄英
神経内分泌腫瘍のバイオマーカーの臨床応用
Mebio 34; 26-31, 2017.3
三木正美、伊藤鉄英
慢性膵炎の病態と治療
消化器最新看護 20(6); 79-83, 2016.2
三木正美、伊藤鉄英
自己免疫性膵炎の診断と治療のポイント
消化器の臨床 20(3); 188-194, 2017
Ito T, Hijioka S, Masui T, Kasajima A, Nakamoto Y, Kobayashi N, Komoto I,Lee L, Ito T, and Jensen RT:
Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies.
Expert Rev Anticancer Ther. 18(9); 837-60, 2018
Hijioka M, Lee L, Igarashi H, et al. :
Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan.
J Gastroenterol. 52(1); 9-18, 2017
Ito T, Jensen RT:
Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies.
Int J Endo Oncol. 3; 53-66, 2016
Ito T, Lee L, Hijioka M, Igarashi H:
Pancreatic endocrine and exocrine functions in patients with autoimmune pancreatitis.
In: Kamisawa T and Chung JB(eds): Autoimmune pancreatitis. Pp. 31-35,
Springer Inc, London, 2015 (分担執筆)
Igarashi H, Hijioka M, Lee L, Ito T:
Biotherapy od pancreatic neuroendocrine tumors using somatostatin analogs.
J Hepatobiliary Pancreat Sci. 22; 618-622, 2015
Ito T, Lee L, Hijioka M, Kawabe K, Kato M, Nakamura K, Ueda K, Ohtsuka T, Igarashi H:
The up-to-date review of epidemiological pancreatic neuroendocrine tumors in Japan.
J Hepatobiliary Pancreat Sci. 22; 574-547, 2015
Igarashi H, Ito T, Lee L, Niina Y, Takayanagi R, Ohtsuka T, Nakamura T, Jensen RT:
Medical management of pancreatic neuroendocrine tumors.
In: Pramod G(ed): ECAB- Pancreatic Tumor. Pp. 154-70,
Elsevier Inc, San Diego, 2013 (分担執筆)
Ito T, Cadiot GH, Jensen RT:
Diagnosis of Zollinger-Ellison Syndrome :Increasingly Difficult.
World J Gastroenterol. 18; 5495-5503, 2012
Ito T, Igarashi H, Jensen RT:
Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances.
J Gastroenterol. 47; 941-960, 2012
Niina Y, Fujimori N, Nakamura T, Igarashi H, Oono T, Nakamura K, Kato M, Jensen RT, Ito T, Takayanagi R:
Pancreatic Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1.
Gut and Liver. 6; 287-294, 2012
Nakamura K, Ito T, Kotoh K, Ihara E, Ogino H, Iwasa T, Tanaka Y, Iboshi Y, Takayanagi R:
Hepatopancreatobiliary Manifestations of Inflammatory Bowel Disease.
Clin J Gastroenterol. 5; 1-8, 2012
Ito T, Igarashi H, Jensen RT:
Pancreatic neuroendocrine tumors:Clinical features, diagnosis and medical treatment:Advances.
Best Pract Res Clin Gastroenterol. 26; 737-753, 2012
Igarashi H, Fujimori N, Ito T, Nakamura T, Oono T, Nakamura K, Suzuki K, Jensen RT, Takayanagi R:
Vasoactive intestinal peptide (VIP) and VIP Receptors -Elucidation of Structure and Function for Therapeutic Applications-.
Int J Clin Med. 2; 500-508, 2011
Moody TW, Ito T, Osefo N, Jensen RT:
VIP and PACAP, recent insights into their functions / roles in physiology and disease from molecular and genetic studies.
Curr Opin Endocrinol Diabetes Obes. 18; 61-67, 2011
【膵外分泌機能不全を再考する】
膵外分泌機能不全の原因と病態 慢性膵炎における膵外分泌機能不全
肝胆膵 90(2); 157-163, 2025.2
藤森 尚、末永 顕彦、川口 夢佳、赤木 健哉、上田 孝洋、梯 祥太郎、安森 翔、大野 彰久、松本 一秀、村上 正俊、植田 圭二郎、伊藤 鉄英、小川 佳宏
【膵外分泌機能不全を究める】
膵外分泌機能不全に伴う糖尿病の病態と治療
胆と膵 46(1); 55-60, 2025.1
高松 悠、伊藤 鉄英、三船 繭子、平賀 ちひろ、新名 雄介、岡本 亮子、植田 圭二郎、藤岡 真之、藤山 隆、藤森 尚
【膵外分泌機能不全を究める】
膵外分泌機能不全に対する栄養サポート
胆と膵 46(1); 61-64, 2025.01
村上 正俊、藤森 尚、宮ケ原 典、赤木 健哉、川口 夢佳、末永 顕彦、上田 孝洋、梯 祥太郎、大野 彰久、松本 一秀、植田 圭二郎、小川 佳宏
【希少領域、治療困難例における膵・胆道癌の薬物療法】
治療困難な膵・胆道癌の薬物療法 閉塞性・拘束性肺障害合併胆道癌・膵癌の薬物療法および薬剤性肺障害について
胆と膵 45(11); 1669-1675, 2024.11
藤森 尚、赤木 健哉、川口 夢佳、末永 顕彦、Gerodias Anthony R.、上田 孝洋、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、植田 圭二郎、小川 佳宏
【胆膵Interventional Endoscopyを極める】
トラブルシューティング 膵管ステント迷入
胆と膵 45(臨増特大); 1377-1383, 2024.10
藤森 尚、小森 康寛、末永 顕彦、植田 圭二郎、小川 佳宏
【スキルアップ内視鏡診療】胆膵 挿管・診断
経口胆道鏡をマスターする
消化器内視鏡 36(増刊号); 343-347, 2024.10
伊藤 鉄英、高松 悠、植田 圭二郎、村上 正俊、松本 一秀、藤森 尚
【膵胆道周囲の後腹膜腫瘍性病変の診断と治療】
膵胆道周囲の後腹膜腫瘍性病変 ～膵神経内分泌腫瘍～
胆と膵 45(9); 915-920, 2024.9
松本 一秀、藤森 尚、上田 孝洋、梯 祥太郎、大野 彰久、村上 正俊、植田 圭二郎、小川 佳宏
【今推しの肝胆膵研究手法と疾患モデル】
新規モデルによる肝胆膵研究 膵臓癌オルガノイドを用いたサブタイプ予測による予後解析
肝胆膵 89(2); 243-248, 2024.8
松本 一秀、藤森 尚、小川 佳宏
オルガノイド研究で膵がん治療を革新したい
国際医薬品情報 1255; 22-23, 2024.8
大野 彰久、藤森 尚、小森 康寛、末永 顕彦、梯 祥太郎、松本 一秀、村上 正俊、寺松 克人、植田 圭二郎、小川 佳宏
【日常診療での超音波検査のおさえどころ】
超音波検査の最新の進歩 胆膵のInterventional EUS
臨牀と研究 101(7); 58-59, 2024.7
松本 一秀、藤森 尚、末永 顕彦、小森 康寛、梯 祥太郎、大野 彰久、村上 正俊、寺松 克人、植田 圭二郎、小川 佳宏
当院における超音波内視鏡下膵管ドレナージ（EUS-PD）の治療成績
膵臓 39(3); A438, 2024.7
大野 彰久、小森 康寛、梯 祥太郎、松本 一秀、村上 正俊、寺松 克人、植田 圭二郎、藤森 尚
膵腫瘤に対するEUSガイド下組織採取（ERS-TA）における再穿刺の意義
膵臓 39(3); A422, 2024.7
植田 圭二郎、高松 悠、藤森 尚、伊藤 鉄英、河村 康平、小森 康寛、末永 顕彦、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、寺松 克人、小川 佳宏
肝転移を伴った膵神経内分泌腫瘍の治療戦略 肝転移を伴う膵神経内分泌腫瘍におけるペプチド受容体核医学内用療法（PRRT）
膵臓 39(3); A225, 2024.7
藤森 尚（回答者）、松本 和幸（質問者；岡山大学病院消化器内科）
小径かつ低悪性度の膵神経内分泌腫瘍に対して経過観察した場合のデータは？経過観察は許容される？
週刊 日本医事新報 No.5215; 50-51, 2024.4
大野 彰久、小森 康寛、末永 顕彦、梯 祥太郎、松本 一秀、村上 正俊、植田 圭二郎、加来 豊馬、藤森 尚
【超音波診断装置を用いたインターベンションにおける合併症予防とトラブルシューティング】
安全で確実なEUS―HGSを目指して ガイドワイヤーの観点から
超音波医学 51; S227, 2024.4
藤森 尚、村上 正俊、松本 一秀、大野 彰久、寺松 克人、植田 圭二郎、伊藤 鉄英、小川 佳宏
【超高齢社会（高齢化率21％以上）の膵疾患診療】
超高齢社会における膵神経内分泌腫瘍診断療
膵臓 39; 33-42, 2024.2
村上 正俊、藤森 尚、末永 顕彦、小森 康寛、梯 祥太郎、大野 彰久、松本 一秀、寺松 克人、植田 圭二郎、伊藤 鉄英、小川 佳宏.
【神経内分泌腫瘍の新たな知見〜膵消化管神経内分泌腫瘍診療ガイドライン改定に向けて〜】
膵・消化管神経内分泌腫瘍におけるliquid biopsy診断.
胆と膵 45; 25-31, 2024.1
藤森 尚、村上 正俊、蓑田 洋介、植田 圭二郎、伊藤 鉄英、小川 佳宏
【神経内分泌腫瘍の新たな知見〜膵消化管神経内分泌腫瘍診療ガイドライン改定に向けて〜】
AIを用いた膵神経内分泌腫瘍治療切除後再発予測モデルの構築と分析
胆と膵 45; 85-93, 2024.1
藤森 尚、小森 康寛、末永 顕彦、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、寺松 克人、植田 圭二郎、伊藤 心二、吉住 朋晴、池永 直樹、仲田 興平、中村 雅史、小川 佳宏
術後膵液瘻に対するStenting Strategy
胆と膵 44(臨時増刊号); 1215-1221, 2023
Fujimori N, Ito T, Ogawa Y.
Diabetes from Exocrine Pancreatic Disease.
Chapter 56, Section 4 : Chronic Pancreatitis
The Pancreas; 445-450, 2023
Ito T, Ueda K, Fujimori N, Jensen RT.
Clinical Manifestation of Endocrine Tumors of the Pancreas.
Chapter 102, Section 7 : Neoplastic Tumors of the Endocrine Pancreas
The Pancreas; 791-798, 2023
Ueda K, Fujimori N, Jensen RT, Ito T.
The Management of Insulinoma.
Chapter 112, Section 7 : Neoplastic Tumors of the Endocrine Pancreas
The Pancreas; 865-871, 2023
大野 彰久、藤森 尚、寺松 克人、植田 圭二郎、小川 佳宏
【特集 胆膵の画像・内視鏡診断の進歩―早期診断と正確な診断のために】
慢性膵炎の画像診断の進歩
臨牀消化器内科 38(13); 1632-1639, 2023.11
藤森 尚、小森 康寛、末永 顕彦、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、寺松 克人、植田 圭二郎、伊藤 心二、吉住 朋晴、池永 直樹、仲田 興平、中村 雅史、小川 佳宏
炎症・体液貯留に対するStenting Strategy 術後膵液瘻に対するStenting Strategy.
胆と膵 44(臨増特大); 1215-1221, 2023.10
植田 圭二郎、伊藤 鉄英、河村 康平、小森 康寛、末永 顕彦、梯 祥太郎、大野 彰久、松本 一秀、村上 正俊、寺松 克人、藤森 尚、小川 佳宏
【特集 胆道癌と膵癌のリスクファクター】
飲酒と発がん
胆と膵 44(9); 815-819, 2023.9
植田 圭二郎、藤森 尚
膵癌患者における糖尿病
胆膵の病態生理 39(1); 37, 2023.6
伊藤 鉄英、高松 悠、渡邉 洋子、植田 圭二郎、永田 宙生、平松 真祐、白石 素公、矢永 勝彦、恒吉 正澄
膵神経内分泌腫瘍と代謝異常
胆と膵 44(5); 453-458, 2023.5
村上 正俊、藤森 尚、小森 康寛、木村 弥成子、大野 彰久、松本 一秀、寺松 克人、植田 圭二郎、伊藤 鉄英、小川 佳宏
ランレオチドによる膵NETに対する抗腫瘍治療
胆と膵 44(1); 53-59, 2023.1
藤森 尚、大野 彰久、植田 圭二郎、蓑田 洋介、小川 佳宏
治療的EUS Peripancreatic/pancreatic fluid collection(PFD)ドレナージ ステントが迷入してしまった
消化器内視鏡 34(12); 1976-1980, 2022.12
藤森 尚、小川 佳宏
慢性膵炎の患者にはどのような生活指導が必要でしょうか？
内科 130(3); 502-505, 2022.9
藤森 尚、松本 一秀、寺松 克人、竹野 歩、小川 佳宏
胆膵疾患の総ざらい 慢性膵炎
内科 130(1); 77-83, 2022.7
村上 正俊、藤森 尚、小森 康寛、木村 弥成子、大野 彰久、松本 一秀、寺松 克人、竹野 歩、植田 圭二郎、伊藤 鉄英、小川 佳宏
膵神経内分泌腫瘍のリキッドバイオプシー
肝胆膵 84(6); 745-750, 2022.6
藤森 尚、大野 彰久、松本 一秀、村上 正俊、寺松 克人、竹野 歩、大野 隆真、小川 佳宏
膵臓の画像診断（CT・MRI・超音波内視鏡）
Medical Technology 50(5); 481-487, 2022.5
村上 正俊、藤森 尚、上田 孝洋、大野 彰久、松本 一秀、寺松 克人、高松 悠、竹野 歩、大野 隆真、伊藤 鉄英、小川 佳宏
膵神経内分泌腫瘍におけるLiquid biopsy診断と治療への応用
胆と膵 43(2); 141-145, 2022.2
藤森 尚、寺松 克人、高松 悠、上田 孝洋、平畠 啓介、大野 彰久、村上 正俊、安森 翔、松本 一秀、竹野 歩、大野 隆真、小川 佳宏.
Liquid biopsyの膵癌切除後のサーベイランスへの応用
胆と膵 43(1); 71-75, 2022.1
松本 一秀、藤森 尚、蓑田 洋介、原 真児登、梯 祥太郎、安森 翔、村上 正俊、寺松 克人、高松 悠、長友 周三郎、西岡 慧、小森 圭司、日置 智惟、川元 美緒、大野 隆真、伊原 栄吉、国府島 庸之、小川 佳宏
膵癌患者由来オルガノイド樹立におけるEUS-FNABと経皮的肝腫瘍生検の有用性の検討（第一報）
日本消化器病学会雑誌 118（臨増大会）; A728, 2021.10
村上 正俊、藤森 尚、梯 祥太郎、松本 一秀、安森 翔、寺松 克人、高松 悠、大野 隆真、小川 佳宏、井出野 昇、森泰寿、池永 直樹、仲田 興平、中村 雅史
当院における膵癌術前化学療法（NAC）無効例の検討
日本消化器病学会雑誌 118（臨増大会）; A760, 2021.10
藤森 尚
慢性膵炎に伴う糖尿病および合併症（治療3）
膵臓 36(3); A112, 2021.8
村上 正俊、藤森 尚、梯 祥太郎、松本 一秀、安森 翔、寺松 克人、高松 悠、大野 隆真、伊藤 鉄英
膵神経内分泌腫瘍の集学的治療 当科における転移性/切除不能膵神経内分泌腫瘍に対する治療戦略
膵臓 36(3); A154, 2021.8
藤森 尚、安森 翔、村上 正俊、松本 一秀、寺松 克人、高松 悠、大野 隆真、伊藤 心二、沖田 興平、中村 雅史
膵癌治療（ステント）膵頭十二指腸切除後膵液漏に対するEUS下膵管ドレナージ 新たな適応の可能性
膵臓 36(3); A295, 2021.8
寺松 克人、大野 隆真、松本 一秀、村上 正俊、高松 悠、竹野 歩、藤森 尚、安森 翔、原 真児登、梯 祥太郎、大野 彰久
末梢血リンパ球亜型と膵癌予後との検討
膵臓 36(3); A301, 2021.8
藤森 尚、村上 正俊、松本 一秀、寺松 克人、高松 悠、竹野 歩、原 真児登、梯 祥太郎、 安森 翔、大野 隆真
膵・消化管神経内分泌腫瘍を巡る最近の話題 NEN診断と治療の新時代 膵・消化管神経内分泌腫瘍(GEP-NEN)の診断の進歩
Pharma Medica 39(5); 66-72, 2021.5
高松 悠、藤森 尚、河邉 顕
消化管狭窄に対する内視鏡治療の現状と課題 悪性胃十二指腸狭窄に対する内視鏡的十二指腸ステント留置術の有用性と予後因子に関する多施設後方視的研究
Gastroenterological Endscopy 63(Suppl.); 772, 2021.4
藤森 尚、蓑田 洋介、大野 隆真
小児に対する内視鏡診療 全身麻酔下超音波内視鏡下穿刺吸引法（EUS-FNA）が治療方針決定に有用であった小児膵腫瘍の2例 小児におけるEUS-FNAの位置付け
Gastroenterological Endscopy 63(Suppl.); 835, 2021.4
安森 翔、村上 正俊、藤森 尚、梯 祥太郎、原 真児登、松本 一秀、寺松 克人、高松 悠、日置 智惟、川元 美緒、大野 隆真
生体肝移植後症例における胆管プラスチックステント迷入のトラブルシューティング
Gastroenterological Endscopy 63(Suppl.); 907, 2021.4
藤森 尚、大野 隆真、中村 雅史
慢性膵炎を巡る諸問題：早期慢性膵炎から外科治療まで 慢性膵炎の経過観察はいつまで必要か？小膵石診断8年後に切除可能膵癌を発症した症例から
日本消化器病学会雑誌 118(臨増大会); A125, 2021.3
藤森 尚、原 真児登、梯 祥太郎、安森 翔、村上 正俊、松本 一秀、寺松 克人、高松 悠、竹野 歩、大野 隆真、伊藤 鉄英、小川 佳宏
慢性膵炎に対する薬物治療
胆と膵 42(2); 113-116, 2021.2
松本 一秀、藤森 尚、末廣 侑大、村上 正俊、寺松 克人、高松 悠、高岡 雄大、大野 隆真、五十嵐 久人、伊藤 鉄英
内科的加療で低血糖を制御し得た高齢発症悪性インスリノーマの一例
膵臓 35(5); 429-438, 2020.10
藤森 尚、高松 悠、松本 一秀、寺松 克人、大野 隆真、小川 佳宏
慢性膵炎の病態（1）成因、疫学
臨床消化器内科 35(11); 1297-1302, 2020.9
植田 圭二郎、下川 雄三、中村 聡、小薗 真吾、空閑 啓髙、西原 一善、藤森 尚、大野 隆真
切除不能膵癌のGnP療法憎悪後生存期間における腫瘍増大パターン・後治療の検討
膵臓 35(3), A321, 2020.7
藤森 尚、松本 一秀、村上 正俊、加来 豊馬、末廣 侑大、寺松 克人、高松 悠、高岡 雄大、大野 隆真、五十嵐 久人、森 泰寿、大塚 隆生、小川 佳宏
胆膵疾患における緊急内視鏡～リスクマネジメントも含めて～. EST後出血（抗血栓薬内服例も含めて）
胆と膵 41(2); 175-181, 2020.7
藤森 尚、末廣 侑大、村上 正俊、松本 一秀、寺松 克人、高松 悠、高岡 雄大、大野 真隆
膵周囲液体貯留に対するlumen-apposing metal stentの治療成績と偶発症
膵臓 35(3), A364, 2020.7
藤森 尚、村上 正俊、末廣 侑大、松本 一秀、寺松 克人、高松 悠、高岡 雄大、竹野 歩、大野 隆真、小川 佳宏
膵癌の日常診療－診断の進め方
臨床と研究 97(5); 537-542, 2020.5
高松 悠、大野 隆真、末廣 侑大、村上 正俊、松本 一秀、寺松 克人、高岡 雄大、藤森 尚、上田 詩織、本坂亜希子、吉澤 裕子、南 晴奈、上野 寿弥、國栖 真理、横山 富美子、盛永 彩香、花田 浩和、濵﨑 正子
慢性膵炎患者に対する多職種連携のサポーティブ・ケアの試み
膵臓 35(2); 180-186, 2020.4
藤森 尚、末廣 侑大、村上 正俊、松本 一秀、寺松 克人、高松 悠、高岡 雄大、大野 隆真、五十嵐 久人、伊藤 鉄英、小川 佳宏
喫煙と慢性膵炎の関係－基礎研究と疫学調査のデータから－
肝胆膵 80(2); 259-263, 2020.2
藤森 尚、松本 一秀、村上 正俊、加来 豊馬、末廣 侑大、寺松 克人、高松 悠、高岡 雄大、大野 隆真、五十嵐 久人、森 泰寿、大塚 隆生、小川 佳宏
胆膵疾患における緊急内視鏡～リスクマネジメントも含めて～. EST後出血（抗血栓薬内服例も含めて）.
胆と膵 41; 175-181, 2020.2
藤森 尚、末廣 侑大、村上 正俊、松本 一秀、寺松 克人、高松 悠、高岡 雄大、大野 隆真、松田 やよい、坂本 竜一、五十嵐 久人、伊藤 鉄英、小川 佳宏
【膵炎大全Ⅱ～膵炎・Up to date～】膵炎の治療 膵性糖尿病の診断と治療
胆と膵 40(臨増特大); 1179-1183, 2019.11
植田 圭二郎、下川 雄三、秋穂 裕唯、藤森 尚、大野 隆真、伊藤 鉄英
【膵炎大全II～膵炎・Up to date～】膵炎の診断方法 膵炎における膵内分泌検査(解説/特集)
胆と膵 40(臨増特大); 1133-1137, 2019.11
肱岡 真之、大野 彰久、加来 豊馬、藤森 尚、大野 隆真、河邉 顕、伊藤 鉄英
【膵炎大全II～膵炎・Up to date～】膵炎の治療 膵炎に対する生活指導および栄養療法の留意点(解説/特集)
胆と膵 40 (臨増特大); 1173-1177, 2019.11
三木 正美、大野 隆真、藤森 尚、李 倫學、伊藤 鉄英
【膵炎大全II～膵炎・Up to date～】膵炎各論 虚血性膵炎(解説/特集)
胆と膵 40 (臨増特大); 1241-1245, 2019.11
藤森 尚、松本 一秀、三木 正美、寺松 克人、高松 悠、高岡 雄大、村上 正俊、末廣 侑大、大野 隆真、荻野 治栄、伊原 栄吉、五十嵐 久人、古賀 裕、伊藤 鉄英、小川 佳宏
膵・消化管神経内分泌腫瘍画像診断のコツと生検の意義
臨床外科 74(9); 1042-1050, 2019.9
藤森 尚、伊藤 鉄英、大野 彰久、松本 一秀、寺松 克人、高松 悠、三木 正美、高岡 雄大、大野 隆真、小川 佳宏
【内視鏡分類2019】胆・膵 膵癌・膵神経内分泌腫瘍 膵嚢胞性腫瘍を除いて
消化器内視鏡 31(4); 676-682, 2019.4
藤森 尚、伊藤 鉄英、大野 彰久、松本 一秀、寺松 克人、高松 悠、三木 正美、高岡 雄大、大野隆真、小川 佳宏
膵癌・膵神経内分泌腫瘍（膵嚢胞性腫瘍除く）
消化器内視鏡 31; 676-682, 2019.4
藤森 尚、伊藤 鉄英、三木 正美、大野 彰久、松本 一秀、寺松 克人、高松 悠、高岡 雄大、大野 隆真、五十嵐 久人、小川 佳宏
膵・消化管神経内分泌腫瘍の切除不能肝転移に対する局所療法
胆と膵 40(2); 161-165, 2019.2
伊藤 鉄英、李 倫学、藤森 尚
【膵神経内分泌腫瘍-診断と治療のパラダイムシフト-】薬物治療 膵神経内分泌腫瘍(NET)の薬剤選択
肝胆膵 78(1); 87-92, 2019.1
三木正美、伊藤鉄英
神経内分泌腫瘍のバイオマーカーの臨床応用
Mebio 34; 26-31, 2017.3
三木正美、伊藤鉄英
慢性膵炎の病態と治療
消化器最新看護 20(6); 79-83, 2016.2
三木正美、伊藤鉄英
自己免疫性膵炎の診断と治療のポイント
消化器の臨床 20(3); 188-194, 2017
Ito T, Hijioka S, Masui T, Kasajima A, Nakamoto Y, Kobayashi N, Komoto I,Lee L, Ito T, and Jensen RT:
Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies.
Expert Rev Anticancer Ther. 18(9); 837-60, 2018
Hijioka M, Lee L, Igarashi H, et al. :
Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan.
J Gastroenterol. 52(1); 9-18, 2017
Ito T, Jensen RT:
Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies.
Int J Endo Oncol. 3; 53-66, 2016
Ito T, Lee L, Hijioka M, Igarashi H:
Pancreatic endocrine and exocrine functions in patients with autoimmune pancreatitis.
In: Kamisawa T and Chung JB(eds): Autoimmune pancreatitis. Pp. 31-35,
Springer Inc, London, 2015 (分担執筆)
Igarashi H, Hijioka M, Lee L, Ito T:
Biotherapy od pancreatic neuroendocrine tumors using somatostatin analogs.
J Hepatobiliary Pancreat Sci. 22; 618-622, 2015
Ito T, Lee L, Hijioka M, Kawabe K, Kato M, Nakamura K, Ueda K, Ohtsuka T, Igarashi H:
The up-to-date review of epidemiological pancreatic neuroendocrine tumors in Japan.
J Hepatobiliary Pancreat Sci. 22; 574-547, 2015
Lee L, Ito T, Hijioka M, Igarashi H, Ueda K, Fujiyama T, Tachibana Y, Kawabe K, Jensen RT, Nakamura K, Kato M, Suzuki K, Takayanagi R:
Current Management of Type 1 Autoimmune Pancreatitis : From the Viewpoint of Pancreatic Endocrine and Exocrine Function.
Autoimmune Dis Ther Approaches: http://dx.doi.org/10.14437/ADTAOA-1-105, 2014
Luo Y, Kawashima A, Ishido Y, Yoshihara A, Oda K, Hiroi N, Ito T, Ishii N, Suzuki K:
Iodine excess as an environmental risk factor for autoimmune thyroid disease.
Int J Mol Sci. 15; 12895-12912, 2014
Ohtsuka T, Matsunaga T, Kimura H, Watanabe Y, Tamura K, Ideno N, Aso T, Miyasaka Y, Ueda J, Takahata S, Osoegawa T, Igarashi H, Ito T, Ushijima Y, Ookubo F, Oda Y, Mizumoto K, Tanaka M:
Role of Pancreatic Juice Cytology in the Preoperative Management of Intraductal Papillary Mucinous Neoplasm of the Pancreas in the Era of International Consensus Guidelines 2012.
World J Surg. 38; 2994-3001, 2014
Aso T, Ohtsuka T, Matsunaga T, Kimura H, Watanabe Y, Tamura K, Ideno N, Osoegawa T, Takahata S, Shindo K, Ushijima Y, Aishima S, Oda Y, Ito T, Mizumoto K, Tanaka M:
"High-Risk Stigmata" of the 2012 International Consensus Guidelines Correlate With the Malignant Grade of Branch Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Pancreas. 43; 1239-1243, 2014
Frilling A, Modlin IM, Kidd M, Russell C, Breitenstein S, Salem R, Kwekkeboom D, Lau WY, Klersy C, Vilgrain V, Davidson B, Siegler M, Caplin M, Solcia E, Schilsky R; Working Group on Neuroendocrine Liver Metastases:
Collaborators (110)Adam R, Akerstrom G, Belghiti J, Breitenstein S, Clavien PA, Frilling A, Gustafsson B, Krenning E, Modlin IM, Norton J, Öberg K, Poston G, Ruszniewski P, Tait P, Toogood G, Russell C, Bouvier C, Jarecki A, Klersy C, Lau WJ, Siegler M, Gustafsson B, Rindi G, Kidd M, Öberg K, Vilgrain V, Baum RP, Heaton N, Poston G, Garden J, Fan ST, Van Gulik T, Sipperstein A, Ruszniewski P, Kwekkeboom D, Caplin M, Gustafsson B, Lawrence B, de Herder W, Ito T, Modlin IM, Rindi G, Perren A, Davidson B, Klimstra DS, Kloppel G, Kidd M, Scarpa A, Meyer T, Knuth A, Chen H, Öberg K, Van Cutsem E, Pavel ME, Kos-Kudla B, Conlon K, Vilgrain V, Imamura M, Kaltsas G, Broering D, Wiedenmann B, Baum RP, Al-Nahhas A, Lodge P, Cosimelli M, Grazi G, Heaton N, Tang LH, Salazar R, Grossman AB, Dejong C, Gores G, Poston G, Nagorney DM, Mazzaferro V, Jensen R, Lesurtel M, Garden J, Falconi M, Hellmann P, O'Toole D, Fan ST, Olauson M, Le Treut Y, Burroughs AK, Mazzaferro V, Van Gulik T, Valle J, Kianmanesch R, Sowa-Staszczak A, Sipperstein A, Milicevic M, Lencioni R, Ramage J, Sangro B, Ruszniewski P, Kennedy A, Bester L, Salem R, Sharma R, Parks R, Kwekkeboom D, Bodei L, Muller-Brand J, Kvols L, Manas D, Caplin M, Ramos J, Pavel ME, Wasan H:
Recommendations for management of patients with neuroendocrine liver metastases.
Lancet Oncol. 15; e8-21, 2014
Fujimori N, Ito T, Igarashi H, Oono T, Nakamura T, Niina Y, Hijioka M, Lee L, Uchida M, Takayanagi R:
Retroperitoneal fibrosis associated with IgG4-related disease.
World J Gastroenterol. 19; 35-41, 2013
Ito T, Igarashi H, Uehara H, Jensen RT:
Pharmacotherapy of Zollinger-Ellison syndrome.
Expert Opin Pharmacother. 14; 307-321, 2013
Kobiyama K, Kawashima A, Jounai N, Takeshita F, Ishii KJ, Ito T, Suzuki K:
Role of extrachromosomal histone H2B on recognition of DNA viruses and cell damage.
Front Genet.4; 1-7, 2013
Ito T, Igarashi H, Jensen RT:
Zollinger-Ellison syndrome: recent advances and controversies.
Curr Opin Gastroenterol. 29; 650-661, 2013
Otsuki M, Koizumi M, Ito T, Shimosegawa T:
Chapter VIII, Aggravation factors and factality rates of acute pancreatitis. -Analysis of a nationwide survet of acute pancreatitis in Japan.
In: Leon VB(ed): Advances in Medicine and Biology. Pp. 147-160,
Nova Science Publishers Inc, New York, 2013 (分担執筆)
Igarashi H, Ito T, Lee L, Niina Y, Takayanagi R, Ohtsuka T, Nakamura T, Jensen RT:
Medical management of pancreatic neuroendocrine tumors.
In: Pramod G(ed): ECAB- Pancreatic Tumor. Pp. 154-70,
Elsevier Inc, San Diego, 2013 (分担執筆)
Ito T, Cadiot GH, Jensen RT:
Diagnosis of Zollinger-Ellison Syndrome :Increasingly Difficult.
World J Gastroenterol. 18; 5495-5503, 2012
Ito T, Igarashi H, Jensen RT:
Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances.
J Gastroenterol. 47; 941-960, 2012
Niina Y, Fujimori N, Nakamura T, Igarashi H, Oono T, Nakamura K, Kato M, Jensen RT, Ito T, Takayanagi R:
Pancreatic Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1.
Gut and Liver. 6; 287-294, 2012
Nakamura K, Ito T, Kotoh K, Ihara E, Ogino H, Iwasa T, Tanaka Y, Iboshi Y, Takayanagi R:
Hepatopancreatobiliary Manifestations of Inflammatory Bowel Disease.
Clin J Gastroenterol. 5; 1-8, 2012
Ito T, Igarashi H, Jensen RT:
Pancreatic neuroendocrine tumors:Clinical features, diagnosis and medical treatment:Advances.
Best Pract Res Clin Gastroenterol. 26; 737-753, 2012
Igarashi H, Fujimori N, Ito T, Nakamura T, Oono T, Nakamura K, Suzuki K, Jensen RT, Takayanagi R:
Vasoactive intestinal peptide (VIP) and VIP Receptors -Elucidation of Structure and Function for Therapeutic Applications-.
Int J Clin Med. 2; 500-508, 2011
Moody TW, Ito T, Osefo N, Jensen RT:
VIP and PACAP, recent insights into their functions / roles in physiology and disease from molecular and genetic studies.
Curr Opin Endocrinol Diabetes Obes. 18; 61-67, 2011
Igarashi H, Ito T, Takayanagi R:
The new concept of therapeutic strategy for neuroendocrine tumors:
the important information from a case report of gastrinoma.
Internal Med. 49; 1839-1840, 2010
Arata S, Takada T, Hirata K, Yoshida M, Mayumi T, Hirota M, Yokoe M, Hirota M, Kiriyama S, Sekimoto M, Amano H, Wada K, Kimura Y, Gabata T, Takeda K, Kataoka K,Ito T, Tanaka M:
Post-ERCP pancreatitis.
J Hepatobiliary Pancreat Sci. 17; 70-78, 2010
Hirota M, Takada T, Kitamura N, Ito T, Hirata K, Yoshida M, Mayumi T, Kataoka K,Takeda K, Sekimoto M, Hirota M, Kimura Y, Wada K, Amano H, Gabata T, Arata S, Yokoe M, Kiriyama S:
Fundamental and intensive care of acute pancreatitis.
J Hepatobiliary Pancreat Sci. 17; 45-52, 2010
Kimura Y, Arata S, Takada T, Hirata K, Yoshida M, Mayumi T, Hirota M, Takeda K, Gabata T, Amano H, Wada K, Sekimoto M, Hirota M, Yokoe M, Kiriyama S, Ito T:
Gallstone-induced acute pancreatitis.
J Hepatobiliary Pancreat Sci. 17; 60-69, 2010